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Abstract
To understand how complex systems, such as cells, function, comprehensive
measurements of their constituent parts must be made. This can be achieved
by combining methods that are each optimized to measure specific parts of
the system. Four such methods, each covering a different area, are presented:
Transcript profiling of one cell type extracted from a complex tissue containing
several cell types; observation and recording of cell motility; measurement of
antibody reactivities using microarrays; and in vivo measurement of free and
bound NADH in mitochondria.
Detailed statistical analysis of the data from such measurements allows models
of the system to be developed and tested. For each of the methods, such analysis
and modelling approaches have been applied and are presented: Differentially
regulated genes are identified and classified according to function; cell-specific
motility models are developed that can distinguish between different surfaces;
a method for selecting repertoires of antigens that separate mice based on their
response to treatment is developed; and the observed concentrations of free and
bound NADH is used to build and test a basic model of respiratory metabolism.
The significance of each of the methods is exemplified by specific results and
insights into the systems analyzed. But also, it is discussed how the methods re-
late to high-throughput biology in general, and how they (and similar methods)
may be combined to rationalize the structure and kinetics of complex networks
of interacting parts in terms of function.
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Abstract in danish
For at forst˚a hvordan komplekse systemer, f.eks. celler, fungerer, ma˚ der udføres
omfattende ma˚linger af alle de enkelte dele i systemet. Dette kan f.eks. gøres
ved at kombinere metoder, der hver især er optimeret til at ma˚le specifikke dele
af systemet. Fire s˚adanne metoder, der hver især dækker e´t specifikt omr˚ade,
præsenteres her: Transkript profilering af en celle type, ekstraheret fra et kom-
plekst væv der best˚ar af flere forskellige celle typer; observation af celle motilitet;
ma˚ling af antistof reaktiviteter vha. microarrays; og in vivo ma˚linger af frit og
bundet NADH i mitokondrier.
Detaljeret statistisk analyse af data fra s˚adanne ma˚linger gør det muligt at
udvikle og teste modeller for systemerne. For hver af de fire metoder er en
s˚adan analyse og modellering blevet anvendt og præsenteres her: Differen-
tielt regulerede gener identificeres og klassificeres efter funktion; celle specifikke
motilitets modeller, der kan se forskel p˚a forskellige overflader, bliver udviklet;
en metode til at udvælge grupper af antigener der kan adskille mus p˚a baggrund
af deres behandlings respons udvikles; og de observerede koncentrationer af frit
og bundet NADH bliver brugt til at udvikle og teste en simpel model for den
respiratoriske metabolisme.
Betydningen af hver af de udviklede metoder eksemplificeres ved de specifikke re-
sultater og indsigter, der er opn˚aet for hver af de systemer, der bliver analyseret.
Derudover diskuteres det, hvorledes de præsenterede metoder generelt relaterer
til moderne biologi, hvor mange parametre ma˚les samtidigt, og hvorledes de (og
andre metoder) kan kombineres for at rationalisere udformningen og kinetikken
i komplekse netværk af interagerende dele ud fra funktion.
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Preface
After three years at Risø National Laboratory (RISØ), one principle has been
constantly emerging in all the projects I have participated in: How fruitful
the interplay between experimental and theoretical work can be. Only thor-
ough analysis and theoretical treatment of experimental results give the insights
needed to direct further improvements and optimization of the experimental
procedures. And only comprehensive understanding of the experiment and un-
derlying biology allows interesting models to be build, tested, and adjusted. In
the development phase, several cycles of experiments, theory, adjusted experi-
ments, adjusted theory, etc., are needed before substantial results are achieved.
When stated, this observation might seem trivial. However, to me, being most
inclined to work on the theoretical and analytical parts of projects, it represent
an insight I believe will increase the quality of my future work.
The work environment and supervision I have received at RISØ has encouraged
me to work on several projects with different groups, mostly biologists. Conse-
quently, I have not had one large project, but instead several smaller ones; some
finished and published now, some still in progress, and some having produced
nothing new. This has been very educational, scientifically as well as towards
developing social interaction skills in multidisciplinary environments. With re-
spect to presenting a coherent thesis, however, it has been a bit of a challenge.
Still, several common themes are present in all of the projects, as I expand upon
in the introduction, and I have structured the thesis around these themes.
Four projects are presented in the thesis, the published items of which are
presented in the next section (Publications), and referred to throughout the
text as papers I, II, III, and IV. For some of the papers, more than one item
has been published or filed, and these are also listed. However, I use the term
“paper”, instead of “project”, since there is only one peer-reviewed publication
per project. The peer-reviewed publications are included at the end of the thesis
(Enclosed publications).
When choosing topics and the level of detail to present them at, I have been
guided by what I would myself have benefitted the most from reading three
years ago when I started the research — with the additional constraint that the
thesis should be kept at a reasonable size.
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Introduction and outline of
thesis work
The success of the natural sciences in explaining the world around us, and in
sometimes even allowing us to manipulate it to our benefit, is based on a certain
way of generating new knowledge: The reproducible observation, or measure-
ment, of some aspect of nature, followed by an interpretation of the measure-
ments — often within the framework of some theory that the measurements
can support or reject. In some cases, one can approach this very stringently by
building a mathematical model that can reproduce the essential trends in the
measurements. The art of building models and matching these to the observed
data is a central theme in the research for this thesis.
Another central theme is the development and application of experimental meth-
ods to observe how molecules interact with each other and their surroundings
at the cellular level. The cell, first observed by Robert Hooke in 1665 using
a compound microscope, has since been recognized as the basic building block
of all living organisms: It stores and processes the hereditary information that
defines the organism, and, through replication and differentiation, it performs
all the specialized functions necessary to sustain the organism. Enclosed by
a plasma membrane, the inside of the cell is like a biochemical factory, with
specialized organelles performing a variety of functions, supported by a myriad
of different molecules. These molecules interact with each other and their sur-
roundings in complex networks, and consequently, in order to understand how
the cell functions and responds to stimuli at a whole-system level, ideally one
needs to be able to measure the amount of each and every molecule in the cell
at the relevant points in time.
System-wide measurements strike at a third central theme of the research for
this thesis: The development and use of computational methods to handle and
analyze large amounts of data in an automated fashion. Large amounts of
data have for a long time been the norm in research fields such as nuclear
physics (for example, once it is operational around 2007, CERNs new particle
accelerator, the Large Hadron Collider, is expected to produce around 15 million
gigabytes of data per year) or meteorology (spacecrafts constantly scan the
earth, creating hundreds of gigabytes of data daily), but have only recently
appeared in biology with the advent of new experimental techniques like genome
sequencing, microarrays, and real-time monitoring and tracking, to name a few.
The thesis is structured as follows: In chapter 1, methods for isolating and ob-
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2 Introduction
serving whole cells are reviewed. The cell’s “phenotypic” response to external
stimuli ranges from the simple observation of, for example successful penetration
of the cell wall by fungi (paper I), to the more complex observation of motility
patterns (paper II). Preparation of cell contents for measurement, specifically
the amplification of DNA, is also treated. In chapter 2, experimental techniques
available to measure the key molecules in the cell or in other well-defined systems
are reviewed. This is divided into measurements at the genome and transcrip-
tome (paper I), proteome (paper III), and metabolome (paper IV) levels. Having
discussed methods for measuring, and thus generating data, in chapters 1 and
2, chapter 3 discusses methods for analyzing the data, specifically the subject of
fitting models to data. Often, the results from such analyses are still complex
and difficult directly to interpret biologically. Chapter 4 discusses various efforts
to relate results to biological knowledge. With the advent of high-throughput
methods, the need for structuring the body of biological knowledge in ways that
are easily accessible by automated queries is paramount. Some of the initiatives
that have been applied with success in the research for this thesis are presented.
Each chapter couples general discussions about methods and techniques with
research examples showing the use of the methods in the research done for this
thesis.
With the three central themes: building and fitting models to data, developing
methods to study cellular functions at a system-wide level, and generating large
amounts of data for which efficient computational methods are needed, the
research for this thesis in general lies within the field of systems biology research.
Each of the papers for this thesis can be seen as an independent attempt to
approach the true system-wide measurement of all relevant aspects of the cell,
for which they need to be combined. Consequently, the title of the thesis work
was coined: Approaches to systems biology.
Building on this, the thesis is concluded with a discussion of the implications and
future directions for the research presented. For some of the projects, additional
datasets have already been generated and are currently being analyzed. In the
spirit of systems biology, attempts at integrating the various sources of data are
presented.
The biological systems and problems studied in this thesis come from a variety
of areas: Grain response to fungus attack, immune response to chemicals with
respect to diabetes development, cell motility response to different biomaterials
to detect biocompatibility, and mitochondrial response to addition of substrate
with respect to the key metabolite NADH. This wide range of problems demon-
strates the general applicability of the methods presented in the thesis. To help
put the research examples presented in the following chapters in perspective,
each of the projects is introduced below.
Single-cell gene expression (paper I)
High-throughput gene expression (or transcript profiling) is well established in
both plant and animal systems (Holloway et al., 2002). However, a limiting
factor in these experiments is the amount of material needed. To get enough
material, large tissue samples are often used. These samples usually contain
a multitude of different cell types in varying amounts, and consequently, only
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transcript profiles that represent averages of the transcript profiles in the indi-
vidual cell types are measured. Also, even if homogeneous tissue samples can
be obtained, the individual cells might be in very different states due to, e.g., a
differential response to external factors.
We have consequently developed a system where (1) individual cells of a given
type are first identified by microscopy. (2) The contents of these cells are then
extracted using micro-capillaries. And (3), the mRNA is isolated, labelled, and
amplified to give amounts sufficient for subsequent detection when hybridizing
to cDNA arrays.
We have tested our method using the interaction between barley and powdery
mildew as the model system. Here, the epidermal cells on the barley leaf are of
primary interest because the powdery mildew attempts to penetrate these cells
to establish a haustoria (fungal feeding structure). Some epidermal cells resist
the penetration by successfully forming a papilla (callose deposition in the cell
wall) at the site of attempted penetration, and others are not successful and
get infected by a haustoria. In addition to this, not all epidermal cells will have
powdery mildew spores interacting with them.
In order to maximize the amount of useful knowledge gained by applying our
method to this system, we have developed a cDNA array that is specifically
suited to measuring transcript activity resulting from this interaction.
In this manner, by micro-extraction of cell-specific mRNA and subsequent cDNA
array analysis, we have successfully obtained separate gene expression profiles
for specific mildew-resistant and -infected barley cells. With the protocols we
have developed, this can be done with as few as 20 cells. Thus, it has been
possible to identify genes that are specifically regulated in infected cells and
presumably involved in fungal establishment.
Cell motility (paper II)
Cell migration is essential in many physiological and pathological processes, e.g.,
embryogenesis, wound healing, inflammation, and metastasis. It is also essential
to emerging medical technologies that rely on colonization of biomaterials by
migrating cells. Many cellular signaling pathways that regulate migration have
been described in recent years (Ridley et al., 2003). The mechano-chemistry
of migration is also studied and modeled in subtle detail (Gaudet et al., 2003,
Ponti et al., 2004, Lauffenburger and Horwitz, 1996, Joanny et al., 2003). Less
is known about the migratory pattern that results from a cell’s processing of all
external stimuli. Although motility models for bacteria have evolved to a high
degree of sophistication (Berg and Brown, 1972, Berg, 2000, 2003, Gerbal et al.,
2000), phenomenological mathematical models for cells from higher organisms
have, with few exceptions (Shenderow and Sheetz, 1997), remained simple.
Using experimental time series for trajectories of two types of motile cells
(NHDF; normal human dermal fibroblast cells, and HaCaT; human keratinocyte
cells) on several types of surfaces (glass, polystyrene, molecular collagen, and
fibrillar collagen), we have developed cell-type-specific motility models. The
two models reflect the cells’ different roles in the organism, it seems, and show
that a cell has a memory of past velocities. Also, differences in the motil-
ity pattern of a given cell type on different surfaces are reflected in different
4 Introduction
values for model parameters. Consequently, these parameter values are quan-
titative cell-and-surface compatibility measures. When designing biomaterials,
such compatibility measures may prove helpful.
Antibody reactivity (paper III)
The antibodies present in one’s body reflects the history of one’s past immuno-
logical experience. However, can the present autoantibody repertoire be con-
sulted to predict resistance or susceptibility to the future development of an
autoimmune disease? To answer this we developed an antigen microarray and
used bioinformatic analysis to study a model of type 1 diabetes developing in
non-obese diabetic male mice in which the disease was accelerated and synchro-
nized by exposing the mice to cyclophosphamide at 4 weeks of age.
We obtained sera from 19 individual mice, treated the mice to induce cyclo-
phosphamide accelerated diabetes (CAD), and found, as expected, that 9 mice
became severely diabetic, whereas 10 mice permanently resisted diabetes. We
again obtained serum from each mouse after CAD induction. We then analyzed
the patterns of antibody reactivities in individual mice to 266 different antigens
spotted on the microarray. A selected panel of 27 different antigens (10% of the
total number on the array) revealed a pattern of IgG antibody reactivity in the
pre-CAD sera that discriminated between the mice resistant or susceptible to
CAD with 100% sensitivity and 82% specificity (p-value= 0.017). Surprisingly,
the set of IgG antibodies that was informative before CAD induction did not
separate the resistant and susceptible groups after the onset of CAD; new anti-
gens became critical for post-CAD repertoire discrimination. Thus, at least for
a model disease, we found that present antibody repertoires can predict future
disease, predictive and diagnostic repertoires can differ, and decisive information
about immune system behavior can be mined by high-throughput technology.
Respiratory metabolism (paper IV)
NAD and NADP are two of the most used coenzymes in cellular metabolism.
More than 500 known enzymes use NAD(P) to catalyze reduction-oxidation
reactions reversibly1. Some of these are amongst the most abundant and well-
studied enzymes participating in energy metabolism (glycolysis, the Krebs cycle,
the Calvin cycle), biosynthesis, degradation, defense against oxidative damage,
etc. NAD(P) is found in mitochondria, chloroplasts, peroxisomes, the cytosol
and other cellular compartments.
Several methods are available for measuring total amounts of the two coenzymes
(Stocchi et al., 1985, Agius et al., 2001), however no quantitative and simple
method for distinguishing between free and bound versions has yet been devel-
oped. Consequently, in spite of the importance of NAD(P) in mitochondrial
metabolism, little is known about the amount of free NAD(P)H, the parame-
ter important for the interaction of the coenzyme with enzymes. Wakita et al.
(1995) were unable to detect free NADH in rat liver mitochondria using fluores-
cence decay analysis. This implies that a small proportion of the total NADH is
free. In contrast, the recent publication of Blinova et al. (2005) reported a high
1www.chem.qmul.ac.uk/iubmb/enzyme (Enzyme Nomenclature)
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relative concentration of free NADH in pig heart mitochondria. This disagree-
ment between the reports from different groups is a basis for confusion about
the role of free NADH in mitochondrial metabolism.
The reduced and oxidized forms of the two coenzymes have distinct spectro-
scopic characteristics — NAD(P)H is fluorescent, while its oxidized form is not.
Further, the fluorescence properties of bound and free NAD(P)H also differ.
Using these fluorescent properties, and building on the qualitative work by Paul
and Schneckenburger (1996), we developed a quantitative method for measuring
both.
We use the developed method to (1) verify the presence of free NADH in mito-
chondria and (2) to investigate its role in the regulation of respiratory processes.
It seems the free NADH concentration is kept constant under different metabolic
conditions. To investigate possible explanations, we build a model that predicts
a 2.5 to 3-fold weaker binding of NADH to mitochondrial protein in state 3
(substrate + ADP present) as compared to state 4 (substrate + ATP).
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Chapter 1
Single cell technology
Animals and higher plants consist of a multitude of distinct tissue types. Fur-
thermore, many of these tissues contains several different cell types, each per-
forming specialized functions. In order to study these functions, single cell
technology is needed.
First and foremost is the observation of single cells. The characteristic size
of single cells is in the µm range, and consequently, the light microscope is a
much-used tool. Of course, for the study of more detailed surface phenomena,
higher resolution may be needed (as for example provided by scanning electron
microscopy).
Having observed the cells; second is the identification of them. This may be
relatively easy if the cells display obvious characteristics and are not moving, or
may require more expertise and, for example, the assistance of computers with
tracking software in the case of motile cells.
Third is the isolation of single cells; for culturing in growth media, or just
for storage in suspension before further processing. For some tissues, cell (or
protoplast) isolation can achieved by enzymatic digestion of the extracellular
matrix (Birnbaum et al., 2003). However, it has been observed that the cells
reacts to this, leading to changes in metabolite, protein, and mRNA levels
(Celis et al., 1999). Another approach is to freeze or fix the tissue and then
dissect the cells using manuel or more sophisticated laser-based techniques, for
example laser capture microdissection, LCM (Emmert-Buck et al., 1996), and
laser microdissection coupled to laser pressure catapulting, LMPC (Schu¨tze and
Lahr, 1998). In LCM, a plastic film is placed over a tissue section containing the
cells of interest. At the spots where the cells are located, an infrared laser beam
then melts the film, effectively making the cells stick to the film. Subsequent
removal of the film also plucks the cells away from the tissue. In LMPC, an
UV-A laser cuts out the cells of interest from the tissue. The excised cells are
then ejected into a tube by a gas pressure cloud that is produced by a defocused
laser pulse. In contrast to LCM, LMPC does not heat up the cells, and therefore
avoids this source of potential damage to cellular components.
Fourth is the extraction of single cell parts or contents. If cells have been isolated
prior to this step, disruption of the cell membranes (lysis) may be sufficient. If
the cell is still located in the tissue, cell contents can be extracted by using a
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glass microcapillary mounted on a micromanipulator to penetrate and aspirate
the cell (Gjetting et al., 2004). Cell turgor is usually considerable and after
penetration the cell contents are driven by it into the capillary tip. The capillary
is then removed from the cell and the sample ejected into a buffer or some other
storage medium. This technique for extraction is minimally invasive since only
the cell in question is disrupted by the procedure (except in the case where the
cell lies below other cells).
Fifth is the processing of cell parts or contents for measurement. Enough mate-
rial must be collected or produced to reach a measurable threshold, for example
by amplifying the mRNA content in the case of gene expression studies.
Three research examples of the use and development of such single cell technol-
ogy are presented below. The first example (Sec. 1.1) concerns the processing
of barley epidermal cells for subsequent hybridization on cDNA arrays. Here,
a central issue is the amplification of the extracted mRNA. A theoretical treat-
ment of this is given in Sec. 1.2, followed by an example of how the reliability
of the amplification can be tested (Sec. 1.3). Sec. 1.4 describes how moving
cells can be monitored and the resulting data be prepared for further analysis.
Finally, Sec. 1.5 gives a few examples of technologies that measure mRNA, pro-
tein, and metabolite amounts in individuel cells, along with a discussion of the
implications.
1.1 Research example: Identification of barley
epidermal cells. Extraction and amplification
of mRNA content (paper I)
Individual resistant and infected epidermal cells of susceptible barley were dis-
tinguished by microscopy of living barley leaves 18 h after powdery mildew in-
oculation (Fig. 1.1). The presence of a papilla (P) subtending the primary ap-
pressorial lobe (L1 ) and formation of a second lobe (L2 ) was used to recognise
and select resistant cells (R) since a second lobe forms only when an effective
host cell papilla prevents attempted penetration from the first. Infected cells (I)
were recognised by the presence of a rudimentary fungal haustorium (H ). The
contents of individual resistant cells, infected cells, and uninoculated control
cells were collected in microcapillaries. The mRNA in the samples was immedi-
ately captured on magnetic beads (coated with strings of T nucleotides to catch
the corresponding polyA tails of the mRNA), purified, reverse transcribed to
cDNA, and amplified using PCR (Polymerase Chain Reaction). During the
amplification, radioactive nucleotides were incorporated in the amplified mate-
rial. Using 35 amplification rounds ensured sufficient material for subsequent
detection after hybridization to the 10k-array (see Sec. 2.1.4).
1.2 Amplification of DNA
To increase the amount of cDNA to detectable levels, in general, two different
amplification strategies can be used (Winter et al., 2002). Linear amplification
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Figure 1.1: Microscope image of the epidermal layer of a barley
leaf inoculated with powdery mildew. I: Infected cell, R: Resistant
cell, H : Haustoria, P : Papilla, L1 : Primary lobe, L2 : Secondary
lobe.
in the form of in-vitro transcription, or exponential amplification, as is achieved
when using PCR.
Linear amplification
For in-vitro transcription, the enzyme RNA polymerase produces new cRNA
transcripts from a population of cDNA templates. Each given cDNA template
is transcribed many times over, producing several identical cRNA sequences.
Let Ni(0) be the number of cDNA templates of a given type, i, present in the
sample to begin with. Let λi be the rate of amplification of this template. After
a time t, the expected number of cRNA sequences transcribed, denoted Ni(t)
will be
Ni(t) = Ni(0)λit
Events (successful amplification) that occur at a definite average rate (λi) is
governed by the Poisson distribution. Consequently, the variance is given by
σ2i (t) = Ni(t) = Ni(0)λit
and the coefficient of variation (the relative variation) by
cvlineari (t) =
σi(t)
Ni(t)
=
1√
Ni(0)λit
(1.1)
Exponential amplification
PCR is based on a thermostable form of the DNA polymerase enzyme. For
a given sequence of cDNA, one needs first to design primers that flank this
sequence. The reaction works in cycles, where each cycle comprises: (1) Dena-
turing of the DNA into two single strands by heating, (2) cooling the solution
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which catalyzes primer annealing to each of the single strands, (3) medium heat-
ing which activates the DNA polymerase to begin producing a complementary
strand to each single strand, starting from the primer, (4) denaturing this newly
formed double-stranded DNA by heating, the same as in (1), etc. Around 30
cycles is common. Compared to the linear amplification method, this method
makes copies of copies. Therefore, it very quickly generates large amounts of
amplified material. However, the variation in the final amount of amplified
material differs markedly from the linear amplification case, as the following
calculation show. Let Mi(0) be the number of cDNA templates of a given type,
i, present in the sample to begin with. Let γi be the probability of successful
amplification of this template in a given round. After k rounds, the expected
number of sequences, denoted Mi(k) will be
Mi(k) =Mi(0)(1 + γi)k
That this is so can be quickly seen when remembering that the series 1, 2, 4, 8, . . .,
which doubles for each successive element, can be written as 2k. Compare with
the above equation when setting γi equal to 1. The equation shows that the
amount of amplified material scales exponentially with the number of rounds,
hence the name exponential amplification. Further calculation show that the
variance can be written
σ2i (k) =Mi(0)(1− γi)
(
(1 + γi)2k−1 − (1 + γi)k−1
)
and thus the coefficient of variation as
cvexpi (k) =
√
(1− γi)
(
(1 + γi)2k−1 − (1 + γi)k−1
)
√
Mi(0)(1 + γi)k
(1.2)
Several papers have been published on the mathematics of PCR. Two papers
that cover the equations mentioned here are Stolovitzky and Cecchi (1996) and
Shaw (2002).
Comparison of linear and exponential amplification
In Fig. 1.2 is shown the coefficients of variation for linear (A) and exponential (B)
amplification. Note that whereas for linear amplification the relative variation
decreases to zero in the limit of t → ∞ (Fig. 1.2A) and (1.1), it reaches an
asymptotic value not equal to zero for exponential amplification (Fig. 1.2B)
and (1.2). This is very unfortunate since only the PCR amplification method
can amplify the small amounts of cDNA converted from extracted mRNA in
reasonable time. However, as the equations show, when amplifying a pool of
different cDNA templates, the final amounts of each template will vary. Thus,
the relative levels of each type of mRNA are not necessarily preserved through
the amplification. Though, as is seen in Fig. 1.2B, the larger the amount of
initial copies of each template, the smaller the cv. That is, it is absolutely
necessary to pool cells until a sufficiently small cv is reached.
In these derivations it was assumed that λi did not change as a function of the
number of rounds. In reality, the experimental protocol needs to be carefully
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Figure 1.2: Coefficient of variation (cv) as a function of (A) time in
linear amplification and (B) rounds in exponential amplification.
Solid lines: 100 cDNA strings, dashed lines: 10 cDNA strings,
dotted lines: 1 cDNA string, as starting material.
prepared in order to insure this, and insure that it as close to one as possible.
Several groups have developed exponential amplification methods that works at
the lower limit of the amount of starting material needed to conserve the relative
abundances of different transcripts (Karrer et al., 1995, Gallagher et al., 2001,
Brandt et al., 2002, Iscove et al., 2002). For the barley epidermal cells described
in Sec. 1.1 we find that mRNA pooled from around 20 cells provides a sufficient
amount for expression analysis. This claim is substantiated by two observations:
(1) By an independent test described below, and (2) by comparing the cDNA
array data obtained using this material to other barley/powdery mildew studies
where the mRNA was not exponentially amplified (described in Sec. 3.3.6).
1.3 Research example: Test of exponential
amplification of single-cell material (paper I)
The test of reproducibility of the exponential amplification is illustrated in
Fig. 1.3 and described below. We extracted and pooled material from 30 in-
fected and 30 control cells. One third of the material from each of these pools
was combined to create a new, mixed sample. This sample thus represented a
biological average of the samples containing pure infected and control material
(Fig. 1.3A). The resulting three samples, each equivalent to 20 cells’ contents,
were PCR amplified and hybridized to small dotblot arrays spotted with 91
ESTs isolated from powdery mildew-infected barley cells (concerning ESTs, see
Sec. 2.1.1). We know that these 91 genes covers a reasonable part of the to-
tal range of expression values in the cell (as measured on the 10k-array, see
Sec. 2.1.4), see Fig. 1.4A, and that about one third are clearly differentially
expressed between the two cases (26 genes are more than two-fold up- or down-
regulated). If the amplification step preserves the original abundance relation-
ships, the expression of each gene measured in the mixed sample should be
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Figure 1.3: (A) One third of a control sample, C, and one third
of an infected sample, I, is mixed together. The resulting three
samples are PCR amplified. (B) If the PCR amplification steps
preserves the relative expression of each gene, the expressions mea-
sured in the mixed sample should equal the average of what is
measured in the control and infected samples.
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Figure 1.4: (A) Coverage of expression range. Boxplots: total
range of expression values on the 10k-array. Red dots: 10k-array
expression values of the 91 genes spotted on dotblot arrays. (B)
Validation of PCR amplification. The average of the expression
values in the infected and control samples as measured on the
dotblot arrays (x-axis) are plotted against the expression values
in the mix of infected and control sample (y-axis).
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similar to the average expression in infected and control material (Fig. 1.3B).
As is seen in Fig. 1.4B, this is clearly the case for the entire range of expressions
intensities. This demonstrated that different genes having different expression
patterns and levels were amplified to a reasonably equal degree (coefficient of
determination r2 = 0.91) and that the protocol developed for PCR maintained
relative transcript abundance levels.
1.4 Research example: Motile human keratinocyte-
and dermal fibroblast cells (paper II)
In the following, techniques for observation and basic data handling of motile
cells are described.
The motility data were obtained from HaCaT cells on substrata of molecular-
and fibrillar collagen (Gadegaard et al., 2003), and from NHDF cells on the same
two collagen substrata, as well as on glass and tissue culture grade polystyrene,
TCPS, all at 37◦C. HaCaT cells did not show measurable motility on glass and
TCPS during the first 24 h of the experiment.
A microscope stage was converted to a temperature-controlled incubation cham-
ber with a computer-controlled step motor for parallel monitoring of several sites
and samples under equal conditions. Cells were monitored in an inverted phase
contrast microscope with autofocusing controlled by dedicated software. A dig-
ital camera recorded time-lapse movies with intervals ∆t of 15min for 24 h.
Only “healthy” cells with full spreading on the substratum and long presence in
the view field were selected from recorded image sequences. One pixel in each
cell nucleus was marked manually as the cell’s coordinate. Cell populations
were dilute, so direct interactions between motile cells were rare. When they
occurred, both cells’ trajectories were excluded from the statistics. Cell trajec-
tories crossing each other were less rare. No effect of this could be discerned.
Data for cell coordinates were corrected for drift, and single cell trajectories were
calculated from position and time data. A number of cells had to be removed
from the statistics because they did not move. Visual inspection of trajectories
would reveal immobile cells. From a number of such inspections, it was found
that they could be excluded automatically, by excluding cells with a root mean
square deviation (RMSD), or standard deviation, that never exceeded 15mm in
the case of HaCaT cells and 20mm in the case of NHDF cells.
For each cell trajectory r(t); the positions rj = r(tj), tj = j∆t, j = 1, 2, 3, . . .
were recorded, and the velocities vj = (rj − rj−1)/∆t were calculated. From
these velocities, the accelerations aj = (vj − vj−1)/∆t were formed. Since
surfaces were manufactured to be homogenous and isotropic to cells, and the
cells’ environment was kept constant in time, we tested and found velocity
distributions consistent with spatial homogeneity and isotropy, as well as with
temporal invariance. Consequently, when computing any ensemble average, we
also averaged this quantity over time, space, and direction to improve statistics.
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1.5 Examples of expression measurements in indi-
vidual cells
Even though the method described in Sec. 1.1 samples individual cells of the
same type, as confirmed by microscopic inspection, it still pools the contents
of several cells in order to reach measurable levels of mRNA. For the biological
questions asked this is not problematic. The idea is to understand the general
(or average) response to infection or resistance, and we do not ask why some
epidermal cells get infected and others do not. However, say that one could, in
fact, measure the transcript profile in individual epidermal cells. Could it be,
that even though epidermal cells are similar in the microscope (before inocula-
tion), their transcript, protein, and metabolite levels are not identical — maybe
even very different in some respects? If so, do these differences determine the
outcome of the attempt to infect the cell? This is an open question. Relating
to this discussion, in Sec. 3.3.8, we show that genetically identical mice display
clearly different antibody profiles. And furthermore, that these profiles can be
used to predict the response to treatment. Now, barley epidermal cells and
mice are clearly different, but the biological mechanism might be the same. To
conclude this chapter and expand on the above stated question, three recently
developed techniques for measuring the amounts of mRNA, protein, or selected
metabolites in individual cells, are presented.
Gene Expression
Using fluorescence in situ hybridization (FISH) and a multiplex probe design,
Levsky et al. (2002) analyzed the gene expression of 11 genes at 14 time points
over a 90min period in individual normal fibroblast cells. FISH is a well estab-
lished method for detecting DNA or mRNA in situ by using labelled oligonu-
cleotide probes (Levsky and Singer, 2003). The introduction of amino-allyl
modified bases allowed the chemical synthesis of multiple-labeled fluorescent
hybridization probes (Femino et al., 1998). And this, in turn paved the way for
applying multicolor FISH to visualization of multiple RNA species simultane-
ously (Levsky et al., 2002). More specifically, it is the synthesis of mRNA that
is monitored by visualizing specific sites of transcription. The results show that
there is considerable cell-to-cell variability, even for synchronized cell-cultures.
It seems that each gene can be thought of as a stochastic variable, subject to
various types of noise, as modelled by Elowitz et al. (2002).
Protein amounts
Hu et al. (2004) have developed a two-dimensional capillary electrophoresis
method for studying the amounts of protein in single mammalian cells. These
cells, containing as little as 50 pg of total protein, are aspirated into a 50µm-
diameter capillary by a brief pressure difference. The cell is then lysed inside the
capillary to release its complement of protein. The proteins are labelled with
a fluorescent tag and then separated inside the same capillary by their molecu-
lar weight (using capillary sieving electrophoresis, which is the capillary version
of conventional polyacrylamide gel electrophoresis). To separate the proteins
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further, successive fractions are transferred to a second capillary. Applying an
electric field across this capillary separates proteins based on their interaction
with the surfactant in a micellar electrophoretic separation. Repeating this
process about 100 times under computer control comprehensively separates the
protein content of the single cell. The minute amounts of protein that result are
detected by laser-induced fluorescence. Using this method, cell-to-cell variation
of protein profiles in cultured breast cancer cells was observed — both before
and after treatment.
Metabolite amounts
Using the same setup with microcapillaries described in the beginning of this
chapter and in Sec. 1.1, one can from the extracted material measure metabo-
lites instead of mRNA levels. From individual cell samples containing as little as
10− 100 pL, the metabolites and compounds nitrate, glucose, fructose, sucrose,
fructans, malate, mannitol, and glucosinolates have been successfully measured
(Tomos and Sharrock, 2001). The measurement technique is based on fluores-
cent microscope photometry linked to an enzymatic redox reaction involving
NAD(P)H. For example, using this method it was shown that the malate con-
centration is approximately six times lower in barly epidermal cells lying close
to stomata (breathing pores on the leaf surface) compared to cells lying further
away from them (Fricke et al., 1995). This observation makes sense since malate
plays a signalling role in the stomatal guard cells, and the transport of malate
from nearby epidermal cells thus needs to be tightly controlled.
16
Chapter 2
Omics methods and
technologies
Consider the large number of different tasks that a cell must perform: Synthesis,
degradation, and exchange of biomolecules in a number of metabolic processes,
maintenance and repair of its constituents, and in general helping the organism
to adapt to the environment (for example by learning, in the case of nerve cells),
to mention a few. Cells can respond to external chemical signals by for exam-
ple growing and dividing, differentiating into specialized cell types, initiating or
halting secretion, starting to proliferate, leaving their place in the extracellular
matrix, or initiating apoptosis. Other external stimuli can also elicit specific
responses: attacks on the plant cell wall by fungi mobilize a myriad of defense
responses such as cell wall strengthening, and the motility patterns of moving
cells are distinctly different when moving on different surfaces — just to name
two examples central to the research for this thesis. Also, cellular dysfunction
may result in serious diseases, for example cancer (uncontrolled cell division)
or Huntington’s disease (continuous aggregation of huntingtin molecules in neu-
ronal cells).
To aid in the description (and perhaps understanding) of how the cell performs
all these functions, one can divide the molecules in the cell into large groups,
depending on their type and function. These groups are: The genome, transcrip-
tome, proteome, and metabolome. The genome is the complete DNA sequence
found in the cell. This includes both genes and non-coding sequences. The suf-
fix “ome” is the Greek word for “all”, “every” or “complete”. When using the
suffix “omics” instead, it is the corresponding field of study that is referred to.
Consequently, genomics is the study of an organism’s genome and the use of the
genes. The mRNA transcribed from the genome is termed the transcriptome.
In contrast to the genome, which is a rather constant entity, the transcriptome
differs from cell to cell and is constantly changing in response to both external
and internal stimuli. Translating the transcriptome we have the proteome (the
entirety of proteins), the large-scale study of their structure and function of
which is the field of proteomics. Finally, there is the metabolome, which is the
complete set of small-molecule metabolites (such as metabolic intermediates,
hormones and other signalling molecules, and secondary metabolites). The me-
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Figure 2.1: Transcriptional and translational mechanisms and
control points for regulation. RR: regulatory region, PTM: post-
translational modification.
tabolome might be the most dynamic of all the omes, changing from second to
second in response to the cell’s needs.
The robust and adaptable behavior of cells ultimately depends on the operation
of complex regulatory biochemical networks spanning the different omes. Even
networks performing “simple” functions are often remarkably complex, involving
proteins, genes, and metabolites in multiple interlocked regulatory loops. To
appreciate this, below, a brief overview of gene expression and its regulation is
presented (Stetter et al., 2003). Simply put, proteins are produced from genes;
they interact with each other and with metabolites but also act back onto the
DNA where they regulate the transcription of mRNA and thus the production
of other proteins, see Fig. 2.1. Starting from the top to the right in this figure,
a gene in the genome is transcribed into mRNA. The non-coding intron regions
are spliced out, and the exons combined1. The spliced mRNA is translated into
an amino-acid chain, the protein. Proteins may be chemically modified (post-
translational modifications) by enzymes before folding into their final shape.
They interact with each other, with metabolites, or with parts of the genome
(transcription factors) or transcriptome (proteins involved in mRNA splicing).
Metabolites may interact with regulatory proteins or mRNA (Kaempfer, 2003).
Finally, external signals can interact with the system as transcription factors or
by modifying transcription factors.
1Exons can be combined in different ways. This is one way to produce several different
proteins from the same gene sequence.
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In the next three sections, experimental methods and technology central for
studying each of the omes and their possible interactions are presented.
2.1 Genomics and transcriptomics
Central to genomics and transcriptomics is knowing the order of nucleotides
in DNA and RNA. Determining this order is called sequencing, and will be
discussed in Sec. 2.1.1. In Sec. 2.1.2, methods for large-scale measurements
and analysis of gene expression are presented. A key technology is microarrays,
which are described in some detail. The preprocessing of microarray data is
specifically discussed in Sec. 2.1.3. Finally, Sec. 2.1.4 presents an example of
the development of a spotted cDNA microarray.
2.1.1 Sequencing
In 1977, two robust techniques for rapid DNA sequencing were introduced: The
enzymatic chain termination method by Sanger et al. (1977), and the chemi-
cal degradation method by Maxam and Gilbert (1977). Since then sequencing
techniques have been improved and automated significantly by e.g. specifically
engineered enzymes and dyes and the use of robots (Sterky and Lundeberg,
2000). To date (March 2006), 355 genomes have been sequenced, divided into 41
eukaryal, 26 archaeal, and 288 bacterial genomes (Liolios et al., 2006)2. Further-
more, in the EST database dbEST3 (Boguski et al., 1993), more than 32 million
EST sequences (see below) have been submitted from 1020 different genomes.
Thus, today there is a vast amount of sequence information stored in public
repositories. The knowledge contained in all these sequences is a cornerstone of
high-throughput modern biology. The fundamental sequencing technique that
has spawned this development will therefore be described in some detail below.
The basic sequencing reaction, based on the enzymatic chain termination method,
consists of (1) the DNA sequence one wants to sequence (the DNA template),
(2) a primer sequence, from which the reaction can be initiated, (3) each of the
four nucleotides (dATP, dCTP, dGTP, and dTTP), (4) the DNA polymerase
enzyme, which, starting from where the primer is attached to the template
string, repetitively inserts complementary nucleotides and thus builds up a new
DNA string, complementary to the template, and (5) limiting amounts of each
of the four dideoxy versions of the nucleotides (ddATP, ddCTP, ddGTP, and
ddTTP). Whenever the DNA polymerase tries to insert one of these into the
growing chain, the reaction will stop and the chain terminate. Since there are
only few of the dideoxy nucleotides in solution compared to the normal ones,
there is only a small chance that the growing chain will terminate at any given
position. In one reaction chamber there are multiple identical DNA templates
and multiple primers, and thus, a nested set of DNA fragments, each termi-
nating at a specific base, are generated. Since each of the fragments are tagged
with a fluorophore that reveals which kind of dideoxy nucleotide that terminated
the reaction, when separating the fragments according to size by running them
2www.genomesonline.org
3www.ncbi.nlm.nih.gov/dbEST/
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through a gel with an electric field applied, one can deduce the sequence of nu-
cleotides in the DNA template by measuring the fluorescent tag each fragment
has as it exits the gel (the smallest fragment containing only a single nucleotide
exits the gel first, the next fragment contain two nucletides, then three, and so
on).
With current technology, DNA strings of maximally around 800 nucleotides can
be sequenced in one reaction. Therefore, when sequencing genomic DNA it has
to be broken up into smaller pieces first. A more direct access to genes, which
can be difficult to locate in genomic DNA, is to reverse transcribe mRNA to
cDNA, and then sequence the cDNA. In this approach, one usually first creates
a cDNA library by inserting the cDNA into viral or plasmid vectors, denoted
cDNA clones. This enables rapid replication of the cDNA, which can then be
sequenced. These sequences are called expressed sequence tags (ESTs).
2.1.2 Methods for large-scale gene expression analysis
Traditionally, Northern or Southern blots have been used to measure gene ex-
pression. Here, the gene of interest in the form of a labelled RNA or DNA string
is incubated with RNA or DNA from the cells of interest. The cellular RNA
or DNA has been separated according to size in a gel, and if a complementary
sequence is present, the labelled string will hybridize to it. After washing, this
can be detected as a band on a x-ray film. The method is not easily extended
to hundreds of genes, and is only semiquantitative.
Two other approaches, both based on PCR, are differential display (Liang and
Pardee, 1992) and real time quantitative PCR (Heid et al., 1996). The latter
method has been used in a 384-well-plate based system, thus measuring the
expression of 384 genes simultaneously4. Although these methods measure the
expression of several, even hundreds of genes, they are still not suited for truly
large-scale gene expression measurements.
Yet another approach to expression profiling is based on sequencing. Here,
random sequencing of cDNA generated from the cells of interest are followed
by counting the number of times each type of cDNA string is sequenced. These
counts reflect the expression of the corresponding gene. The method is denoted
serial analysis of gene expression, SAGE (Velculescu et al., 1995).
DNA microarrays is by far the method that is most commonly used today
for large-scale gene expression analysis. Microarray technology is not limited
to genomics and transcriptomics. In general, a microarray consists of a solid
surface onto which a large number (from around 1000 to 50000) of molecules
with specific binding properties have been chemically attached. The idea is
that these molecules can act as probes for molecules in a solution (effectively a
reverse Northern blot in the case of gene expression). Depending on the type
of probe, several types of microarrays have been devised. The first microarray
created was a DNA microarray (Schena et al., 1995), in which labelled DNA
molecules in a solution hybridizes to complementary DNA on the array. Other
examples of microarrays are protein microarrays, tissue microarray, or antigen
4products.appliedbiosystems.com/ab/en/US/adirect/ab?cmd=catNavigate2&catID=
600759&tab=DetailInfo
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microarrays, in which antigen probes on the array will bind specific antibodies
in a serum sample (see Sec. 2.2.3). In the following, DNA microarrays will be
described in some detail (and will simply be referred to as microarrays).
There are two main technologies for making microarrays: robotic spotting and
in situ synthesis. For the spotted microarrays, the solid surface is usually either
a glass slide or a nylon membrane. A spotting robot is used to put the probes
on the surface, the probe material being for example PCR products or presyn-
thesized oligonucleotides. To aid in the subsequent detection, the probes are
arranged in an orderly fashion on the array, for example equidistantly in rows
and columns.
For the in situ synthesized microarrays, oligonucleotides are built up base by
base on the surface of a glass slide. Each base added to the oligonucleotide on
the array has a protective group to prevent the addition of more than one base
during each round of synthesis. The protective group is then removed with either
light or acid (depending on the type of protective group used) before the next
round of synthesis. So, in each addition cycle, the following steps are performed:
(1) The photo- or chemolabile group on the oligonulceotides in a specific region
are deprotected using either light or acid. (2) Nucleotides (either A, C, T or
G) are flushed over the array, binding to the exposed oligonucleotides. (3) The
remaining free nucleotides are removed. And (4), the uncoupled nucleotides are
capped by chemically inactivating the reactive hydroxyl group.
When using light as the method for deprotection, two approaches are currently
used to direct the light to the relevant regions of the array: (1) By using a mask
that allows light to pass to some regions but not to others (each round of syn-
thesis then requires a different mask). This is the method used by Affymetrix5.
And (2) by having an array of computer-controlled micromirrors, which can be
adjusted to direct light on the appropriate regions of the array. This is the
method used by Nimblegen6 and Febit7.
Instead of using light for deprotection, one can also use chemical deprotection
with synthesis via inkjet technology. At each step of the synthesis, droplets of
the appropriate base are fired onto the desired spot on the glass slide using what
is essentially an inkjet printer. This is the method used by Rosetta8, Agilent9
and Oxford Gene Technology10. The advantage of the micromirror and inkjet
technology over the use of masks for deprotection is that the array can contain
exactly the oligonucleotides the array-maker wishes. That is, it is highly flexible.
However when using masks, once the masks have been made, a large number of
identical arrays can be produced efficiently. The in situ synthesized microarrays
have a lower variation between technical replicates than the spotted microarrays,
but are generally more expensive. A number of less conventional microarray
technologies are also being developed. For example, the use of semiconductor
chips as solid support. The oligonucleotides are then build up by activating
specific electrodes that deprotects the oligonucleotides by an electrochemical
5www.affymetrix.com
6www.nimblegen.com
7www.febit.de
8www.rii.com
9www.chem.agilent.com
10www.ogt.co.uk
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reaction (CombiMatrix11 and Nanogen12).
Microarrays can also be used to detect mutations or polymorphisms in spe-
cific genes. On these arrays, groups of individual sequences differ only from
each other by a single or a few nucleotides. Since these microarrays geno-
type whole genomes by measuring Single Nucleotide Polymorphisms (SNPs)
across the genome, they are called SNP- or genotyping microarrays (Kidgell
and Winzeler, 2005). By combining SNP-microarray analysis with knowledge
about haplotypes (sets of nearby SNPs on the same chromosome that are inher-
ited in blocks), as for example recently published for the human genome (The
International HapMap Consortium, 2005), genes involved in inherited diseases
can be comprehensively identified.
2.1.3 Using microarrays
Several steps are needed before data from microarray experiments can be ana-
lyzed. The slides need to be scanned and the resulting images segmented into
spot and background regions. The background intensity must be removed and
an estimate of the intensity of the material hybridized to each spot calculated.
Finally, all spot intensities on each of the microarrays in the experiment must be
normalized to adjust for systematic effects. These normalized intensities then
hopefully provide reasonable estimates of the expression of the corresponding
genes. The individual preprocessing steps are discussed in more detail below. In
general, for each step, a range of methods are available. Diagnostics that can be
performed to help select the optimal method are described and also, in the end
of this section, a general scheme for systematically testing which combination
of preprocessing steps is the optimal for a given technology and experiment is
presented.
Scanning
The hybridized material is labelled with either a fluorescent or radioactive tag.
When using radioactive tags, such as the beta-emitting radioisotope 33P in-
corporated into the nucleotide triphosphate molecules, the detection process,
denoted phosporimaging, consists of two steps. (1) The radiation from each
spot is detected using a phosphor storage screen. The detection layer in such
screens consists of BaFBr:Eu crystals. When an europium (Eu) electron is ex-
cited by the radiation, it is trapped in the crystal lattice structure producing a
stable BaFBr:Eu3+ crystal. (2) The screen is then scanned with a laser. When
the laser hits the crystals containing excited electrons, they are released and
emits fluorescent light upon returning to the ground state. This emitted light
is detected by a photomultiplier tube and recorded (e.g. in a TIFF file).
When using fluorescent tags, the array is scanned directly and the emitted light
from each spot detected and recorded. Fluorescence has the advantage that
samples labelled with different fluorescent tags can be mixed and hybridized to
the same array (two-color cDNA arrays). Also, effects such as overshining (see
11www.combimatrix.com
12www.nanogen.com
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below) are avoided. On in situ synthesized oligonucleotide microarrays only one
type of fluorescent tag is used.
The resolution of the resulting images differs depending on the type of array
and the technology used. For glass slides spotted with fluorescent material,
spot diameters usually range from 25–50µm and the resolution is around 3µm
per pixel. Radioactive spots on nylon membranes are usually larger (around
0.5mm), and are also scanned at lower resolution (around 50µm). In both
cases, each spot is contained in around 100 pixels.
During the scanning of microarrays hybridized with fluorescent material, noise
can influence the measurements, sometimes quite drastically, producing out-
lier pixels with much higher or lower intensities than the pixels around them.
Usually, the microarray is only scanned once. However, if the array is scanned
several times, this could potentially be used to detect such outlier pixels and
remove them (Romualdi et al., 2002). Otherwise, noisy pixels, etc. are usually
handled in the segmentation phase.
Segmentation
In the following, only segmentation of images from spotted microarrays are
described. For in situ synthesized oligonucleotide microarrays, the individual
oligonucleotides are located with such precision, and so close together, that
that there is no need for the methods described below.
Having scanned the spotted microarray and obtained an image of it, next is the
segmentation of the image into spot and background regions. Ideally, only the
spots should emit light and thus be easily separated from the black background.
In reality however, the background also binds some of the labelled material.
In addition, dust particles, contaminations, smears of spot material over large
areas, etc. are also often seen. Therefore, algorithms are needed that can classify
pixels into spot and background. The first step in segmentation is to place a
grid over the image. The grid is adjusted so that each grid square contain one
spot. Methods to automate this process have been proposed (Jung and Cho,
2002, Galinsky, 2003), however they have yet to come in widespread use.
With the grid in place, several different algorithms have been developed that
attempt to separate spot from background. A simple approach is the fixed circle
algorithm. Here, a circle with a predetermined diameter is placed in the grid
square in a manner that maximizes the difference between the pixel intensities
inside the circle and outside the circle. One can extend this method and use
two circles, the one larger than the other. The pixels between the two circles,
corresponding to a transition area, are discarded, and this usually gives better
estimates for spot and background intensities. Often spot sizes are not uniform.
To accommodate this one can let the algorithm optimize both the position and
the diameter of the circles (adaptive shape algorithm). Sometimes spot shapes
are not even circular, or artifacts such as smears from other spots partly overlay
the spot. To handle these situations, the histogram method or the seeded region
growing algorithm have been proposed. The histogram method removes the
lowest and highest intensity pixels found in the spot and background regions
respectively, according to predetermined thresholds. The seeded region growing
algorithm takes another approach. First, a set of pixels called seeds have to be
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specified (for example, the pixels in the center of the grid square are the spot
seeds and those on the grid intersections are the background seed). Then, the
seeds are grown by defining a rule concerning the adoption of pixels adjacent to
seeds. Usually the adjacent pixel with the intensity that is closest to the average
of the seed pixel intensities is adopted as a seed. Finally, a rule for stopping the
process has to be defined.
The choice of segmentation method can significantly influence the quality of the
data. Studies that compare methods generally show that histogram- and seeded
region-type methods are superior to the fixed or adaptive circle methods (Yang
et al., 2002, Ahmed et al., 2004) (although the first paper puts more emphasis
on choosing an appropriate background correction scheme, as discussed below).
Hybrid methods that implement both histogram and seeded region growing have
recently been reported to give even better results (Rahnenfu¨hrer and Bozinov,
2004).
In the end, the goal is to develop a segmentation pipeline that performs all
the steps automatically, and attempts at this have been proposed (Jain et al.,
2002, Angulo and Serra, 2003). In general, however, different microarrays pose
different problems, and methods (or combinations of methods) have yet to be
developed that clearly perform well for all of them. Until such a time, informed
manual intervention in the process is definitely advantageous when one wants
to ensure high quality data.
Summary values and quality measures
Having segmented the pixels in each grid square into spot and background
pixels, summary values can calculated. For example, to represent the intensity
in a spot, the mean or median of all spot pixels can be used. For high intensity
spots, a common problem is that a fraction of the spot pixels are saturating.
That is, for 16-bit TIFF images, their intensity is 216 − 1. In reality, these
pixels should have had higher values, but due to the settings of the scanner,
their intensity exceeds what can be measured and stored. By calculating the
standard deviation of spot pixels in each spot, such saturation can be detected
since the spot standard deviation in these cases will be low. Instead of discarding
such spots, or use the biased summary values, one could replace the saturating
pixels with an estimate of their real values. Such estimates, based on censored
regression (Dodd et al., 2004), or spot shape modelling (Ekstrøm et al., 2004),
have recently been proposed.
Other summary values, that function as quality measures, can be calculated,
for example spot size, variation in background pixels, circularity, and signal-to-
noise ratio (difference between spot and background intensity measured in units
of the spot standard deviation). These quality measures can be used to evaluate
the individual spots, perhaps discarding some, or to adjust their spot intensities
(Wit and McClure, 2003). One could also calculate an overall measure of quality
which can then be used to weigh intensities in subsequent analyses (Wang et al.,
2001, Brown et al., 2001, Bylesjo¨ et al., 2005).
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Overshining
Specifically for radioactively labelled arrays, it is important to correct for over-
shining. Since there is a small distance between the nylon membrane and the
phosphor screen (due to the plastic wrapping of the membrane and the overcoat
on the screen), and because radiation emits equally in all directions, the width
of the intensity profile detected on the screen will depend on the intensity of
radiation in the spot on the array. Therefore, the more radiation a spot emits,
the larger the spot will be. Also, much of the intensity measured in background
regions, and often also some of the intensity in the spots themselves, contains
significant contributions from radiation emitted from neighbouring spots. Three
approaches to solve this problem have been suggested. Therneau et al. (2002)
uses an image deconvolution method to sharpen the images before segmenta-
tion. Machl et al. (2002) suggest to take advantage of replicate spots to calculate
the average percentage that each spot overshines into neighboring spots, and
then use this to correct spot intensities. And finally, Lopez et al. (2004) has
calculated the spot profile one would detect from radioactive material uniformly
distributed in a disk, and uses this to deduce the “real” intensity in each spot.
In reality, however, spot material is often irregularly distributed and tends to
aggregate in donut shapes.
Background correction
If the intensity measured in a spot, Itot, is simply the intensity of the back-
ground in that spot, Ibgr, plus the intensity from the spotted material, Imat,
one could estimate the background intensity in the spot from the intensity in
the background region around the spot, Ibgr ≡ Iaro, and subtract this number
from the total spot intensity measured. This difference would then represent the
intensity of the spotted material, Imat = Itot−Iaro. Depending on the quality of
the estimates of Itot and Iaro, sometimes this is not the case. For example, when
subtracting an overestimated background value from a low intensity spot, one
might get a value below zero. And also, the variance between replicate spots
for which the background has been subtracted may increase rather drastically
(the difference of two noisy numbers). Several approaches have been suggested
to avoid this. These range from the very simple ones where spots with nega-
tive values are removed from the dataset, to log-linear interpolation methods
(Edwards, 2003), and methods that fit specifically chosen distributions to the
foreground intensities using the background intensities as a covariate (Smyth,
2005).
A simple way to evaluate the performance of the segmentation and background
correction is to plot the estimates of the background intensities against the back-
ground corrected spot intensities. If the background corrected spot intensities
correctly represent the intensities from the spotted material only, there should
be no dependence on the background intensities visible in the plot. That is, the
points should scatter randomly and should not display a trend such as scattering
around a line with positive slope.
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Normalization
In order to be able to compare samples hybridized to different arrays, the only
differences between samples should be the ones that are biologically interesting.
That is, the differences that characterize the response to different treatments,
etc. However, unequal quantities of starting mRNA, differences in labelling or
detection efficiencies, or other array- or sample-systematic biases are the norm,
and these need to be removed before comparisons can be made. This process is
called normalization of the data. There are several approaches for normalizing
microarray data. The simplest being the division (or subtraction if logarithms
have been taken, see Sec. 3.3.3) of a constant such that the mean-, or median
expression, is equal to 1. This assumes that the differences between arrays affect
all spots on a given array equally. Often this is not the case, which can be seen
e.g. by plotting all intensities on one array against all intensities on another
array. If the slope of this plot is different from 1, the artifacts perturbing the
measurements are intensity dependent. In this case, normalization methods
such as quantiles (Bolstad et al., 2003), lowess (Yang et al., 2002), or qspline
(Workman et al., 2002) may be used. As an example, the qspline method is
described in more detail below.
By xki is meant the intensity of spot k in array i. The geometric mean (vk) of
each spot is calculated as
vk =
(
I∏
i=1
xki
)1/I
This forms the distribution which all the arrays are scaled against. The geo-
metric mean is used instead of the mean because the distribution of x’s is asym-
metric, having a long tail for high x. This is also the case for log-transformed
intensities. From the distribution of the vk’s and the distribution of the xki’s
in each array, the 100 percentiles are calculated and placed in the vectors
qv = (q1v, q2v, . . . , q100v) (for v) and qi = (q1i, q2i, . . . , q100i) (for each of the
arrays). A cubic spline function, si(x), is interpolated between the points
{(q1i, q1v), (q2i, q2v), . . . , (q100i, q100v)}. The cubic spline function for array i
now represents the normalized expression indices. That is, the mapping, from
raw to normalized expression indices is given by xij → si(xij).
Optimization of preprocessing steps
The material presented below relies both on the topics presented above, and
on the topics concerned with statistical testing discussed in Sec. 3.3. Instead
of postponing the material presented here to chapter 3, I will simply assume in
the following that Sec. 3.3 has been read.
If it were known beforehand which genes would be differentially regulated in
an experiment, one could evaluate different combinations of preprocessing steps
by their ability to reveal those genes upon subsequent statistical testing. That
is, keeping the statistical test the same, by determining the combination of
preprocessing steps that allow the largest percentage of the total number of
differentially regulated genes to be detected. Of course this should not be at
the expense of also detecting a lot of false regulations. What is needed is the
combination of preprocessing steps for which the statistical test is maximally
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sensitive (TP/TP + FN) and specific (TN/TN + FP). In reality, such a situa-
tion is only achieved if the samples used for hybridization have been artificially
constructed. For example, by creating samples of 3860 cRNAs each, where 1309
of them differed in varying amounts between three control samples and three
‘spiked’ samples, Choe et al. (2005) showed that for Affymetrix microarrays,
the following combination of preprocessing steps allowed detection of approxi-
mately 70% of the true positives at FDR < 0.1: subtracting unspecific signal
from the perfect match probe intensities and performing an intensity-dependent
normalization at the probe set level. However, usually such spiked datasets are
not available and it might even be that the data structure resulting from a given
experiment requires a different combination of preprocessing steps than what
was determined using a spiked dataset for the same technology platform.
One suggestion for a quality measure for real datasets is to calculate the ratio
between biological variance (variance between different sample types) and mea-
surement variance (variance between replicates). Thus, the measure is an F -like
statistic averaged over all genes. Thygesen and Zwinderman (2004) have shown
that it might be best not to use this ratio directly but instead calculate a p-value
under the null hypothesis of no biological variance. The distribution of the ra-
tio, needed for such a p-value calculation, can be computed by constructing a
number of permuted datasets and calculate the ratio for each of these.
Another approach is to focus on the results of the statistical testing. For exam-
ple, for each of a number of preprocessing combinations, by plotting the number
of genes detected as differentially regulated (TP + FP) against the number of
these genes that are false positives (FP), for a range of significance levels α.
One can then choose the combination that performs the best by identifying the
curve that has the fewest false positives at any significance level compared to
the sum TP + FP (He et al., 2003). To use this method one have to correctly
estimate the number of false positives. The best way to do this depends on the
experimental design. For example, if several replicates are available, one could
randomly divide them into two groups and test for differentially regulated genes
between these groups. Any genes detected would constitute false positives. The
random division into two groups could be done a number of times and the es-
timate of the number of false positives be calculated as the average number of
genes detected as differentially regulated for each division.
2.1.4 Research example: cDNA array (paper I)
The barleyPGRC1 10K cDNA array
To detect mRNA amplified from barley (Hordeum vulgare L., cv. Pallas) epider-
mal single cell samples as described in Sec. 1.1, a cDNA array (the barleyPGRC1
10K cDNA array, abbreviated the “10k-array”) was developed. It consists of
two nylon membranes spotted with 10 297 unigenes. In the following, the basic
manufacture of the array, as well as the hybridization and preprocessing of the
array data, are presented.
The barley genome has not been sequenced yet. However, many ESTs have
been created. For the 10k-array, a total of 41 600 barley ESTs of more than
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100 bp length were selected from the cDNA libraries generated at the Insti-
tute of Plant Genetics and Crop Plant Research, Germany (Ku¨nne et al., 2000).
Specifically, the HO library, which is primarily derived from barley infected with
powdery mildew (Blumeria graminis (DC) Speer f.sp. hordei), and thus partic-
ularly useful to our study, were included. All ESTs were clustered into groups
sharing significant sequence similarity. The resulting clusters and singleton se-
quences (sequences that did not cluster) thus represent a non-redundant set of
gene-oriented sequences. That is, each cluster and singleton sequence hopefully
correspond to a unique gene, and they are therefore denoted unigenes. When
comparing the unigenes on the 10k-array to the genes on the Affymetrix Barley
Genome Array (Close et al., 2004), 15% of the genes are unique to our array.
For each unigene, one representative clone associated with the longest EST
sequence was selected. Each of the selected cDNA clones was PCR amplified
and after purification and two-fold concentration by ultrafiltration, resulting in
an estimated DNA concentration of 50 ng/mL, mixed 1:1 with spotting solution.
The DNA was then robotically spotted in duplicate onto nylon membranes using
a 0.2mm pin tool. Five strokes of the pin tool were applied to each spot resulting
in the transfer of approximately 50 nL material.
Hybridization and scanning
We hybridized 12 10k-arrays with amplified and radioactively labelled material
from the cell specific samples (see Sec. 1.1); 3 with material from resistant cells,
3 with material from infected cells, 3 with material from non-inoculated control
cells, and 3 identical samples for technical replication, made by pooling equal
amounts of material from the 3 infected samples. The radiation from each spot
was detected by phosphorimaging and the results stored in TIFF files.
Segmentation and correction for overshining
For radioactively labelled material, the more material hybridized, the larger the
spot (see Sec. 2.1.3). Therefore, images were partitioned into spot and back-
ground regions using fixed circle segmentation (diameter of circle equal to 0.4
mm, and on average 0.3 mm between circles in the horizontal or vertical direction
in the subgrid). For each spot we calculated the average of the corresponding
pixel intensities. Due to the above-mentioned radiation effects, much of the in-
tensity measured in background regions, and often also some of the intensity in
the spots themselves, contains significant contributions from radiation emitted
from neighbouring spots. To correct for this we used a straightforward exten-
sion of the approach described by Machl et al. (2002). Briefly, on each nylon
membrane we compare the differences between intensities in replicated spots to
the differences between the sums of intensities in their respective neighbouring
spots. This yields an overshining coefficient c, which is the percentage that
each spot overshines into neighbouring spots. Since the overshining coefficient
is distance dependent we divide it into two coefficients, one for first neighbours
(the four neighbouring spots directly above, below or to the sides), denoted c1,
and one for second neighbours (the remaining four neighbouring spots on the
diagonals), denoted c2. We found that on average for all arrays c1 = 0.3% and
c2 = 0.1%. Therefore, especially in the case of low intensity spots with high
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intensity neighbours, the overshining has a significant contribution and the cor-
rection for it is important. By measuring the background intensity close to the
edge of each nylon membrane (where the effect from overshining should be min-
imal) we found no significant location-dependent variation in the background
intensity. Consequently we calculated an overall average background intensity
on each array from the pixel intensities around the edge of the membrane.
Data preprocessing
Each of the following steps was performed sequentially. (1) For each spot, the
background intensity was subtracted from the spot intensity. (2) Spot intensi-
ties were corrected for overshining as described above. (3) All intensities were
log2-transformed. This resulted in reasonably constant variability at all inten-
sity levels. (4) The intensity of each probe was calculated as the mean of the
intensities of the two replicate spots on each array. (5) No intensity-dependent
overall differences between arrays were detected. Therefore, to remove overall
differences in intensities between arrays, the intensity of each probe on each
nylon membrane was normalized by subtracting the median of the intensities
on each membrane. The background subtracted, overshining corrected, nor-
malized, mean-log2 intensity of a probe is denoted the expression of the gene
corresponding to that probe. All raw and processed data are stored in the
ArrayExpress database13, accession number E-MEXP-457.
Division between plant and fungal genes
The barley cDNA libraries used to design the 10k-array, especially the library
made from powdery mildew-inoculated barley, may contain some fungal se-
quences. To make sure that we only included barley genes in our analyses, fun-
gal sequences were detected and removed as follows: For all genes on the array,
sequences that showed high similarity (using both BLASTN and TBLASTX,
see Sec. 4.1) to fungal sequences (an E-value less than 10−20) over plant se-
quences (no hits less than 10−20) were removed. Here, the fungal sequences
were from the Cogeme database14 and the plant sequences constitute the rice
(Oryza sativa15) and Arabidopsis16 genomes combined. Out of the 10 297 uni-
genes on the 10k-array, 225 were identified as fungal genes in this manner and
removed.
2.2 Proteomics
Loosely speaking, more things can be measured and investigated when it comes
to the proteome compared to the genome and transcriptome. For example, pro-
teins get phosphorylated and glycosylated — endowing them with a lot more
decorative elaboration than is found in DNA. Of course, DNA also has methyla-
tion and a few other modifications, but nothing like the complexity of proteins.
13www.ebi.ac.uk/arrayexpress
14cogeme.ex.ac.uk/sequence.html
15ftp.tigr.org/pub/data/Eukaryotic_Projects/o_sativa/
16ftp.arabidopsis.org/home/tair/home/tair/Sequences/blast_datasets/
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The outline of this section largely follows that of the Sec. 2.1. Techniques for se-
quencing and identification of proteins are discussed in Sec. 2.2.1. Proteins can
interact with each other, forming stable or transient complexes. The reason for
forming complexes are numerous and include the ability to increase turnover
rates of metabolites by having all pathway enzymes closely together, and to
avoid crowding in the confined space of the cell by packing the protein ma-
chinery (Ellis, 2001). Experimental approaches for identifying protein-protein
interactions are discussed in Sec. 2.2.2. Also discussed in Sec. 2.2.2 are several
techniques for large-scale measurement of protein amounts, specifically protein
microarrays. Finally, Sec. 2.2.3 presents an example of the development of an
antigen microarray.
2.2.1 Sequencing and identification
To determine the amino acid sequence of a protein one can use Edman degrada-
tion (Shively, 2000). The Edman degradation sequentially removes one residue
at a time from the amino end of a peptide. The separated residue is identi-
fied using high-pressure liquid chromatography, HPLC. In HPLC, the residue
is forced through a column (stationary phase) by a liquid (mobile phase) at
high pressure. The time it takes to pass the column identifies each amino acid
uniquely. By repeated degradations, a sequence of around 50 amino acids can
be determined in one experiment.
In general, it is easier to sequence mRNA than proteins. And having obtained
the mRNA sequence one can easily deduce the resulting amino acid sequence.
Therefore, instead of sequencing a protein directly in order to identify it, one can
often use the following approach: (1) Digest the protein with a a trypsin, thus
creating a number of peptides, (2) measure the molecular mass of each peptide,
and (3) compare this with translated known mRNA sequences that has been
digested virtually in a similar manner (using an algorithm that implements the
properties of the trypsin). The most common method for mass determination
is mass spectrometry (MS). Here, an ionizer transfers the peptides into gas
phase ions and accelerates them towards a mass analyser. The mass analyzer
separates the ions according to their mass/charge ratio. After separation, the
ions are then detected by an ion detector (Mann et al., 2001). This is only the
basic principle of MS, and different types of MS have been developed that can
be used for different applications.
2.2.2 Methods for large-scale proteome analysis
Interactions
Interactions between proteins are primarily determined on a large-scale by one
of the following two methods: Yeast-two-hybrid screens (Fields and Song, 1989)
or purification of tagged protein complexes followed by mass spectrometry (Ae-
bersold and Mann, 2003).
The basic idea of the yeast-two-hybrid system is to connect the transcription of a
reporter gene to the successful interaction between two proteins of interest (say,
proteins A and B). That is, only if the proteins interact will the reporter gene
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be transcribed. The reporter gene is transcribed when a specific transcription
factor (Gal4) binds upstream of it. This transcription factor has two parts, a
DNA-binding domain (which binds to the upstream sequence) and an activation
domain (which is needed for the RNA polymerase to attach and transcribe the
reporter gene). These two parts are separated, the DNA-binding domain fused
with the gene encoding protein A, and the activation domain fused with the
gene encoding protein B. When the fused genes are transcribed, the chimeric
protein A, fused with the DNA-binding domain, will bind upstream of the re-
porter gene. Only if protein A and B interacts will the chimeric protein B,
fused with the activation domain, also be bound in the upstream region of the
reporter gene, and the reporter gene be transcribed. The experiment can be
carried out thousands of times on microassay plates, as described by Uetz et al.
(2000). Disadvantages of the method are that there have been reported high
false positive rates (proteins are identified as interacting when they in reality
do not), and only pairwise interactions are tested.
In the large-scale purification of protein complexes, fusion proteins are used as
well. Here, the protein of interest is fused to a tag. This tag is a peptide that
can be used to separate the protein from the solution by binding to an antibody
which again binds to an immunoglobulin-bound solid support (affinity purifi-
cation). When purifying the protein through its tag in this manner, proteins
interacting with the tagged protein will also be retrieved. The proteins in the
purified complexes are separated by gel electrophoresis and identified by mass
spectrometry. Such an approach has been carried out for hundreds of complexes,
as described by Gavin et al. (2002).
Besides the experimental approaches outlined above, several computational ap-
proaches have been developed to detect putative protein-protein interactions.
These usually involve comparisons across species, for example, conservation of
gene order, gene fusions, or conservation of phylogenetic profiles (Orengo et al.,
2004). Also, genes encoding proteins in stable complexes often display similar
gene expression profiles (Hahn et al., 2005).
To reduce the error rates in protein-protein interaction datasets and increase
their coverage of the proteome, different datasets can be combined. The simplest
rules for integration of datasets is to use ‘and’ or ‘or’ rules. That is, all datasets
must agree on an interaction (and), or, at least one dataset must predict the
interaction (or). Obviously, the ‘and’ rule results in accurate datasets with low
coverage, whereas the ‘or’ rule trades coverage for accuracy. It has recently been
shown (Xia et al., 2004) that using machine learning methods to integrate the
datasets in general yields superior results compared to the simple ‘and’ or ‘or’
rules.
Currently, around 2000 different types of interactions have been identified (being
derived from the total set of all interactions measured), and there is probably
around 10 000 different types of interactions all in all (Aloy and Russel, 2004).
Consequently, much work still has to be done before a comprehensive coverage
of interactions is obtained.
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Amounts
In parallel to Northern and Southern blots discussed for RNA and DNA in
Sec. 2.1.2, Western blots can be used to detect individual proteins. Tradition-
ally, large-scale analysis of protein amounts have been conducted using 2D-gel
electrophoresis (Dunn and Gorg, 2001). Here, a protein mixture is loaded onto
a polyacrylamide gel and separated in the first dimension by a pH-gradient (by
applying an electric field) and in the second dimension by molecular mass. The
proteins are stained and appear as spots in the gel. To identify the proteins in
each spot, they are cut out and analyzed by mass spectrometry. There are, how-
ever, several problems with the method: The proteins in the gel are degraded
over time and consequently one cannot take too long identifying them. Also,
large variations between gels from similar samples have been observed. Finally,
there may be several proteins in the same spot, making both the functional
characterization and identification of such spots difficult.
Specifically for antibodies in, for example, serum (blood plasma without clotting
factors), amounts can be measured using the Enzyme-Linked Immunosorbent
Assay (ELISA) technique (Lai et al., 2005). The steps of ELISA are: (1) Apply
and fix a sample of known antigen to a surface. Often, 96 well plates are used,
and each well loaded with a different antigen. (2) Each of the wells are then
coated with the serum sample. Antibodies in the serum that are specific to any
of the immobilized antigens will bind. (3) The plate is washed so that unbound
antibody is removed. After this wash, only the antibody-antigen complexes re-
main attached in the well. (4) Secondary antibodies are added to the wells.
These will bind to any antigen-antibody complexes. (5) The secondary anti-
bodies are coupled to a substrate-modifying enzyme, and when applying this
substrate, a chromogenic or fluorescent signal is elicited. (6) The amount of
antibody in each well can then be quantified using a spectrophotometer. Such
a method has for example been used to analyze patterns of 87 autoantibodies
in 20 healthy persons and 20 persons with type 1 diabetes mellitus (Quintana
et al., 2003). It was shown that these patterns can discriminate between healthy
persons and persons with type 1 diabetes mellitus. However, the method does
not easily scale to thousands of antibodies.
As mentioned in Sec. 2.1.2, besides DNA microarrays, much effort has been
invested in developing protein microarrays: High-throughput devices for mea-
suring amounts of individual proteins. Proteins are more challenging to prepare
for microarrays than DNA, due to for example large differences in binding con-
stants between different proteins immobilized on the array. When reviewing
the literature on protein microarray technology, topics such as optimal surface
chemistry, capture molecule attachment, and protein labelling and detection,
get much attention (Zhu and Snyder, 2003). Several types of protein microar-
rays have been developed. Depending on what is attached to the solid support,
examples are: tissue microarrays (Kononen et al., 1998), peptide microarrays
(Fodor et al., 1991), antigen microarrays (Robinson et al., 2002; paper III),
universal protein microarrays (Ge, 2000) and carbohydrate microarrays (Wang
et al., 2002). The preprocessing of protein microarrays follow the same steps as
outlined in Sec. 2.1.3. In the next section, the development and preprocessing
of an antigen array will be presented. Before this, however, one remark concern-
ing coverage. Taking humans as an example, compared to the around 30 000
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genes comprising the genome, it is currently believed that the proteome consists
of around one million different proteins (Stetter et al., 2003). This increase is
for example due to post-transcriptional and post-translational modifications as
briefly mentioned in the introduction to this chapter. In any given type of cell,
only a fraction of the entire proteome is expressed. Still, however, the number
of different proteins that need to be measured to provide a reasonable coverage
of the entire set of expressed proteins is expected to be quite large, and out-
side the capability of current technologies. A representative example of current
technology being the work by Horn et al. (2006). In this study, a protein array
consisting of 37 200 recombinant human proteins was developed to profile the
autoantibody repertoire of dilated cardiomyopathy patients.
2.2.3 Research example: Antigen array (paper III)
A total of 266 antigens was selected for the microarray. These includeded pro-
teins, synthetic peptides from the sequences of key proteins, nucleotides, and
phospholipids. In general, the antigens can be divided into three groups: (1)
those that are known to be involved with diabetes, (2) those that in general
are connected with autoimmune diseases, and (3) “chance” antigens, not known
to be connected with autoimmune diseases but central with respect to the pro-
cesses they are involved in. The antigens were diluted in phosphate buffered
saline (PBS) and placed in 384-well plates at a concentration of 1µg/µL. From
these wells a robotic arrayer with solid spotting pins of 0.2mm were used to
spot the antigens onto super-epoxi microarray substrate slides. Each antigen
was spotted in two to eight replicates. The spotted microarrays were stored at
4◦C.
Before incubation with test serum, the microarrays were washed with PBS and
blocked for 1 h at 37◦C with 1% bovine serum albumin (BSA). They were then
incubated overnight at 4◦C with a 1:5 dilution of the test serum in blocking
buffer under a coverslip. Next, the arrays were washed and incubated for 45min
at 37◦C with a 1:500 dilution of a goat anti-mouse IgG Cy3-conjugated anti-
body. The arrays were washed again, spin-dried, and scanned. The results were
recorded as TIFF files.
The pixels that comprised each spot in the TIFF files and the local background
were identified by histogram segmentation. The intensity of each spot and its
local background were calculated as the mean of the corresponding pixel inten-
sities. None of the spots containing antigens showed saturation. Technically
faulty spots were identified by visual inspection and removed from the data set.
For each spot, the local background intensity was subtracted from the spot in-
tensity. Spots with negative intensities after this correction were removed from
the data set. A log2-transformation of the intensities resulted in reasonably
constant variability at all intensity levels. The log intensity of each antigen was
calculated as the mean of the log intensities of the replicates on each slide. To
remove overall differences in intensities between arrays, the mean log intensity
of each antigen on each array was scaled by subtracting the median of the mean
log intensities of all antigens on the array. The scaled mean log intensity of an
antigen is denoted the reactivity of the antigen. The processed data set consists
of a matrix of IgG reactivities, consisting of 266 rows and 38 columns (two sam-
ples for each of the 19 mice). Each column contains the reactivities measured
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on a given array and each row contains the reactivities measured for a given
antigen over all arrays. Additionally, the reactivity for each antigen measured
before and after cyclophosphamide treatment in each mouse was combined into
a log ratio by subtracting the reactivity before treatment from the reactivity
after treatment. This combination yielded a matrix of ratios with 266 rows and
19 columns.
2.3 Metabolomics
Much important knowledge can be gained from profiling the metabolome. Me-
tabolites, being the intermediates of biochemical reactions, link together a web
of interactions, pathways, and participants such as DNA, mRNA, proteins, and
environmental stimuli. In essence therefore, the metabolome directly reflects
the current status of the cell, and is indicative of the effect of differences in
transcript or proteins amounts between different sample types. Concerning
the network topology of the metabolome, consider the following example from
primary metabolism in fungi (Jewett et al., 2006): (1) More than 70% of all
metabolites participate in more than just two reactions, (2) Most reactions re-
quire more than one substrate and one product, and (3) the average path length
from any metabolite to any other metabolite is around 3. The metabolome is
thus highly connected and it might be that small pertubations are propagated
to, and therefore detectable in, large parts of the network.
However, the point made in Sec. 2.2.2 concerning the current technological in-
ability to measure the entire proteome is even more pertinent in metabolomics.
Here, the current inability to comprehensively profile the entire metabolome is
related to its chemical complexity, the biological variance due to e.g. the speed
of metabolite turnover, and the dynamic range limitations of the instruments
used (Sumner et al., 2003). Multiple technologies are used, including optimized
versions of mass spectrometry, nuclear magnetic resonance, and laser induced
fluorescence. It is expected that several technologies need to be combined to
comprehensively measure the metabolome (Sumner et al., 2003). However, when
targeting specific parts of the metabolome where metabolites have reasonably
similar properties, using GC/TOF MS, the profiling of as many as a 1000 me-
tabolites have been reported (Weckwerth et al., 2004).
For metabolites that are in dynamic equilibria between free and bound states,
the problems of measurement are paramount since they have to be performed in
vivo in order not to destroy the equilibria. One such central molecule is NADH,
the measurement of which is the topic of the following example.
2.3.1 Research example: NADH monitoring (paper IV)
The basic approach developed for measuring free and bound NAD(P)H is as
follows. First, measure and estimate the spectra of free and bound NAD(P)H
in vitro. Next, use these spectra to decompose in vivo measured spectra of
total NAD(P)H into their free and bound components. The spectrum of free
NAD(P)H is easily measured. The spectrum of bound NAD(P)H is estimated
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from a series of mixtures that contain varying amounts of free and bound
NAD(P)H. Below these steps are described in more detail.
Preparation of mitochondria
Mitochondria were isolated from potato tubers (Solanum tuberosum L., cv. Bin-
tje) by differential centrifugation followed by Percoll density gradient centrifu-
gation essentially as described by Struglics et al. (1993). In these mitochondria,
no NADPH has been detected (Agius et al., 2001). Consequently, although
NADH and NADPH have similar fluorescence characteristics, in the following,
we assume that only NADH contribute to the spectra. Total NADH and NAD+
was extracted from mitochondria and quantified by enzymatic assay essentially
as described by Ciotti and Kaplan (1957).
Fluorescence measurements
The fluorescence instrument was developed on-site, specifically for investigat-
ing NADH turnover in biological samples. Briefly, fluorescence was induced by
the third harmonic of a Q-switched Nd:YAG laser at 355 nm. The laser pulse
duration was 5 ns with 1-ns jitter and the pulse repetition rate was 10Hz. Flu-
orescence emission was detected through the transparent wall of an oxygraph
sample cell, perpendicular to the incident light. The emitted light was collected
on the entrance slit of a spectrometer and detected by an ICCD camera. The
controller/pulse generator unit coordinated the onset of a laser pulse and the
delayed data collection, which was triggered by the Q-switch of the laser. The
gate width was 20 ns centered at the peak of the laser pulse intensity, thus en-
suring equilibrium between the excitation and the emission processes. Such a
data collection window allows determination of the “steady-state” data, where
the quotation marks indicate a certain approximation of the term, when applied
to our method.
Binding of NADH to model proteins
In order to decompose in vivo measured spectra of NADH into their free and
bound components, the spectrum of NADH bound to mitochondrial proteins
had to be obtained. Since NADH binds to a wide range of known and unknown
proteins, this task cannot be accomplished without certain assumptions. To
investigate how the spectrum of bound NADH depends on the binding strength
we first measured the binding parameters of several selected proteins by isother-
mal titration calorimetry, ITC (Leavitt and Freire, 2001). Further, the spectral
properties of these systems were studied as described above. The model proteins
included a mitochondrial malate dehydrogenase (MDH) from pig heart and a
non-mitochondrial protein with an NADH-specific binding site: yeast alcohol
dehydrogenase (ADH). BSA has not been reported to have a specific binding
site for NADH and was used as a model for unspecific binding of NADH to
proteins.
The calorimetric measurements were conducted at 25◦C. NADH and/or pro-
teins were dissolved in 5mM HEPES-KOH, pH 7.5. Concentrations of the
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proteins and NADH were determined spectrophotometrically (Hirayama et al,
1990).
The protein solution, typically between 2 and 10mg/mL, was loaded into the
sample cell and titrated with a concentrated solution of NADH. The experiments
were designed so that the amount of injected ligand at the end of a titration
experiment was twice the number of potential binding sites of the protein. A
model with one set of independent binding sites was fitted to the resulting data,
and association constants estimated from this. They ranged from 104M−1 (in
the case of unspecific binding to BSA) to 106M−1.
Spectra of free and bound NADH
The fluorescence of NADH in the presence of BSA or ADH shows that the en-
vironment of the binding site primarily affects the fluorescence intensity of the
bound cofactor and not the spectral shift. That is, binding to an unspecific
site (such as in BSA) shifts the emission maximum to the same extent as when
NADH is bound to a specific site (as in case of ADH). This ensures that the spec-
tra of free and bound NADH are the same in vivo as in vitro, and consequently
that the concentration of free NADH is properly estimated when decomposing
spectra. The concentration of bound NADH however, can be over- or under-
estimated, as the actual average binding constant of mitochondrial proteins is
below or above the one assumed from the model system.
From the above considerations, we selected yeast ADH as the model protein with
an intermediate between specific and unspecific binding properties for NADH.
This model system was routinely tested prior to the beginning of the experiments
with the mitochondria.
The spectrum of free NADH was measured directly on the solutions of pure
NADH at different concentrations. The linearity of the fluorescence signal with
the concentration of NADH was ensured by using low concentrations (i.e. 1–
10µM. Using the binding parameters obtained from ITC, the concentrations
of free and bound NADH were calculated for the three standard mixtures of
NADH and ADH (Table 3.1 and Fig. 3.9A in Sec. 3.4.1). These systems were
designed to contain the same amount of total NAD(H) as our biological system,
calculated with the assumption that the isolated mitochondria from potato tu-
bers contain 1–2 nmol NAD(H)/mg protein (Agius et al., 2001). Since we used
1–2 mg protein per mL in the assay, the maximum concentration of NADH in
the assay would be 1–4µM. From the spectra of the standard mixtures the
spectrum of bound NADH could be calculated (Fig. 3.9B). This calculation is
the subject of Sec. 3.4.1.
2.4 Integration of the omics
Studies that integrate high-throughput data from several omes are appearing
more and more frequently. Expression profiles of cell-cycle genes have been
combined with protein-protein interaction data to show how functional protein
complexes are dynamically assembled and reassembled during the life-cycle of
the yeast cell (de Lichtenberg et al., 2005). Gene expression (22 810 genes) and
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metabolome (1800 metabolites) data have been combined to study flavonoid
biosynthesis in Arabidopsis plants overexpressing the PAP1 gene (Tohge et al.,
2005). And Conway and Kinter (2005) identified significantly overexpressed
antioxidant and antioxidant-related genes and proteins in connection with the
uptake of oxidized low density lipoprotein by macrophages (using Affymetrix
microarrays and 2D gel electrophoresis coupled with MS) — just to mention
three recent examples. Another obvious application of integrated datasets is for
classification purposes of, for example, cancer cell types.
Important for the proper integration of the omes is knowledge about how they
relate to each other, and much experimental and theoretical work is still needed
in this area. An instructive example of this was presented by Karp (2004)
and is the following: The number of biochemically characterized enzymes is
around 5000 to 6000. However, only for around 60% of them is the amino acid
sequence known. The remaining 40% functionally characterized enzymes cannot
be integrated with genomics and transcriptomics data: Genes encoding these
enzymes cannot be identified and possible transcriptional control can therefore
not be inferred.
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Fitting models to data
Having measured all the compounds constituting each of the omes, as well as
their connections, etc., hopefully, the basic experimental knowledge needed to
really figure out how it all works together has then been established. That is,
the knowledge needed to rationalize the structure and kinetics of the networks
in terms of function. To achieve this, however, not only experimental knowledge
is needed. Also, theoretical tools that can structure and explain the data, need
to be developed and applied (Tilstone, 2003).
This chapter presents examples of fitting models to data from all four papers
included in this thesis. As such, the chapter is not meant to provide a compre-
hensive review of building models and fitting them to data. Rather, the idea is
to provide the theoretical background needed for the models built and fitted in
the papers. Still, the sections progress from simple to more advanced examples
with respect to fitting. In Secs. 3.1 and 3.2, a quantitative method for fitting,
the least squares method, is presented. This introduces the basic notation and
prepares for the following sections. A simple application of least squares is given
in Sec. 3.3. The fits presented in this section, however, only form the starting
point for the more general subject of testing for differential expression of com-
pounds between conditions. These methods are used in papers I and III and are
also treated in Sec. 3.3. In Sec. 3.4, a geometric interpretation of least squares
fitting is presented as preparation for the use of spectral decomposition in paper
IV. In general, when fitting models that are linear in the parameters, solutions
can be calculated analytically. However, for nonlinear models, e.g. differential
equations without closed form solutions, numerical methods must be used. This
subject is presented in Sec. 3.5 and applied in papers II and IV. Finally, Sec. 3.6
discusses stochastic models and how they can be used to study cell motility
(paper II).
3.1 Maximum likelihood estimation
In essence, the task of fitting a model to data can be formulated as follows: Let
the data be a collection of N events corresponding to the measurement of an
independent variable xi and a dependent variable yi, where i = 1, . . . , N . The
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model is some function f that relates the measured independent and dependent
variables given a set of model parameters aj , j = 1, . . . ,M , that is
f ≡ f(xi, a1, . . . , aM )
When fitting, one wants to adjust the parameters in the model in such a way
that each measured yi is as close as possible to the value predicted by the model
at that point f(xi, a1, . . . , aM ). The formulation of a sensible measure of “as
close as possible” is the subject of this and the next section.
Often, we can assign a probability to each data point. That is, we might know
the probability ∆Pi = pi∆y that, for a given xi, any one measurement will give
an answer between yi and yi + ∆y. Here, pi is the probability density. Using
this, the task of fitting can now be stated as: Given a model with a particular
set of parameters, what is the probability that the measured data could have
occurred? The parameter values should then be chosen so that this probability
is maximized. This is the principle of Maximum Likelihood Estimation.
3.2 Least squares fitting
When a measurement yi is influenced by many small random and independent
perturbations, the probability distribution for this measurement will almost
always follow the normal distribution. The reason is that the probability distri-
bution of the sum of a lot of a small random numbers almost always converges
to the normal distribution, as proved in the central limit theorem. When using
the normal distribution for maximum likelihood estimation, it is usually referred
to as least squares fitting. The following calculation shows the reason for this.
Assuming that measurement errors are independent and normally distributed,
the probability P that the N events (xi, yi) could have come from a model which
predicts the values (xi, f(xi, a1, . . . , aM )), is given by
P =
N∏
i=1
pi∆y
=
N∏
i=1
1
σi
√
2pi
exp
[
− 1
2
(
yi − f(xi, a1, . . . , aM )
σi
)2]
∆y (3.1)
where σi is the standard deviation of the measurement yi. Since N , σi, and
∆y does not depend on the parameters aj , maximizing (3.1) is the same as
minimizing the sum
χ2 ≡
N∑
i=1
(
yi − f(xi, a1, . . . , aM )
σi
)2
(3.2)
called the “chi-square”. Differentiating (3.2) with respect to the parameters aj
gives a set of equations which must hold at the chi-square minimum.
To summarize: The minimization of the χ2 represents the quantitative method
used to reach the optimal fit of a model to data. Since the χ2 is the sum of the
squared difference between the observed measurements and predicted values,
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weighted by the standard deviations; and it is this value we want to minimize,
the method is also called least squares fitting. The rationale being that by
minimizing this quantity specifically, one maximizes the probability that the
model with the determined parameters could yield the measurements.
By error propagation, the variance in each of the parameters can be calculated
as
σ2(ai) =
N∑
i=1
σ2i
(
∂ai
∂yi
)2
which put error bars on the parameter estimates. The overall fit is in general
deemed reasonable if χ2 divided by the degrees of freedom, χ2/(N −M), is of
order one or less. The reason for this being that if the model is correct, the
expected value for χ2 is equal to N −M . Therefore, even with just one set of
measurements, if the model is the correct one, it would be highly unlikely that
χ2 is much larger than N−M . A more quantitative notion of this is to compare
χ2 to the chi-square distribution for N −M degrees of freedom, and calculate
the probability of obtaining a value ≥ χ2 by chance (Bevington and Robinson,
2004).
3.3 Simple models for high-throughput experiments
In high throughput experiments, thousands of genes, proteins, or metabolites are
measured under a number of different conditions. For simplicity, gene expression
will be used as an example in the following sections, but the methods described
are of course generic to all kinds of high-throughput experiments.
Consider a single gene whose expression has been measured under t different
conditions. One usually chooses a very simple model to describe the gene’s
expression under condition k (where k = 1, . . . , t) namely that it is expressed
at a given level ak. Keeping to the notation introduced in Sec. 3.1, for each
condition there is one such model, written as
fk = ak, k = 1, . . . , t
where σk is the standard deviation of the measurements. For each condition
the gene’s expression, yki, has been measured nk times (so i = 1, . . . , nk), and
consequently, the χ2 for each model can be written
χ2k ≡
nk∑
i=1
(
yki − ak
σk
)2
Taking the derivative of this with respect to ak and setting equal to zero gives
ak =
1
nk
nk∑
i=1
yki
So, for each condition, the least squares fit is simply the average of the measured
gene expressions.
Having determined the average expression of the gene under each condition is
just the beginning. What one is usually interested in is whether the gene is
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Figure 3.1: Expression values for two genes, A and B, measured
at three conditions each. The expression of each gene at each
condition is measured a number of times, thus allowing calculation
of mean values and standard deviations. These are illustrated with
boxplots (the box indicates the standard deviation, the whiskers
indicate all measurements).
differentially expressed between conditions. A straightforward approach to this
would be simply to use the standard deviations σk as error bars on each average
expression ak and inspect whether they overlap or not. Figure 3.1 illustrates this
for two genes measured under three conditions each. They have the same mean
values for each condition but since the standard deviations for gene A are much
smaller than for gene B, it appears more certain that gene A is differentially
regulated than gene B. The next section puts this line of thought on more solid
statistical ground.
3.3.1 Testing hypotheses, the F-statistic
A gene is either differentially expressed between two or more conditions, or it
is not. This can be formulated as the two mutually exclusive hypotheses
H0 : a1 = a2 = · · · = at (the average gene expressions are equal)
H1 : at least one equality is not satisfied
where H0 is the null hypothesis, representing the status quo where the gene is
not differentially regulated and H1 is the alternative (or research) hypothesis
where the gene under at least one condition has an expression different from
the rest. When testing these hypotheses the basic idea is to calculate a test
statistic whose probability distribution can be specified. Using this we can
then calculate the probability of incorrectly rejecting the null hypothesis, the p-
value. The lower the p-value, the less likely it is that the gene is not differentially
regulated.
Since the errors on the measured gene expressions should reasonably be the
same no matter the condition, it is in the following assumed that the variances
are the same under each condition, that is σ2k = σ
2. Furthermore, to keep things
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simple, only the balanced case where nk = n is considered. The intuition readily
extends to the unbalanced case, which just involves lengthier calculations.
Remembering the consideration of the standard deviations of genes A and B in
the last section (Fig. 3.1), a straightforward approach for testing the hypothe-
ses is to calculate two independent estimates of the variance σ2, one of them
assuming that the null hypothesis is true. The ratio of these variances could
then be compared to the F -distribution, which is the distribution of the ratio
of two estimates of the same variance of a normal distribution1. The longer out
in the tail that the ratio of variances (the F -statistic) is, the less likely it is that
the variances are equal.
One estimate of the variance σ2 can be derived by first calculating the variance
for each condition
s2k =
1
n− 1
n∑
i=1
(yki − ak)2
and then take the average of these variances
s2within =
1
t
t∑
k=1
s2k
This estimate has t(n− 1) degrees of freedom. Since it is calculated by looking
at the measurements within each condition, the subscript “within” was chosen
for this estimate.
Another estimate of the variance can be calculated if the null hypothesis is
assumed to be true. It is simple to show that the sample mean computed from
a random sample of size t from a population with mean µ and variance σ2 is
a random variable with mean µ and variance σ2/t (Bevington and Robinson,
2004). In the present case we have t conditions with means ak and variances σ2.
Consequently the variance of the mean expressions is given by σ2/t. An estimate
of this variance is calculated using the mean expressions as observations
s2between =
t∑
k=1
(ak − a)2/(t− 1)
where a is the average of the mean expressions. It follows that ts2between is an
estimate of σ2 with (t − 1) degrees of freedom. The suffix indicates that it is
derived from the variance between the mean expressions of each condition.
The ratio of the two variance estimates
ts2between
s2within
is the F -statistic. The larger this ratio, the further out on the right tail of the
F -distribution is the statistic, and the less likely it is that the null hypothesis is
true. To summarize backwards, the larger the spread is between at least one of
the average gene expressions and the rest (s2between), compared with the spread
1Consequently, the F distribution is uniquely identified by the degrees of freedom (number
of samples minus one) of each variance estimate.
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of values within each condition (s2within), the less likely it is that the gene is
expressed to the same level under all conditions.
When comparing only two conditions, testing based on the F -statistic is the
same as performing a two-tailed t-test. However, the F -statistic can be applied
to quite complex experimental designs. Consider for example an experiment
measured under four different conditions. The experiment is designed to test
the effect of two factors, treatment and time, with two levels each: no treatment
and treatment, 2 h and 24 h. It is a full factorial design, that is, the four different
conditions exactly cover all factor level combinations. One could then proceed
with testing the effect of each factor in isolation (main effect) and in combination
(interaction effect) by calculating F -statistics for each. Used in this way the
analysis is called Analysis of Variance (ANOVA), in the example used here,
specifically two-way ANOVA.
When each factor has more than two levels, a problem with this approach is
that one does not know which of the levels are different from the rest. A way
to remedy this is to use post-hoc comparisons such as for example Fishers least
significant difference procedure, Duncan’s multiple-range test, or just pairwise
t-tests with correction for multiple testing (Freund and Wilson, 2003). However
in general, preplanned comparisons have more power. Consequently, if it is
known which comparisons (contrasts) are of interest, one may define these to
begin with, and then test each one using the F -statistic. An example of such
a contrast, using the two-factor experiment mentioned above, could be: Which
genes respond differently to treatment at 2 h and 24 h?
When using the F -statistic to test for differential regulation in gene expres-
sion experiments, several issues need to be considered. First of all, are the
assumptions fulfilled? That is, are replicate measurements normally distributed
and have equal variance? And second, in most gene expression measurements,
thousands of genes are tested. What cutoff value (significance level) should be
chosen to divide genes into those that are, and those that are not, significantly
differentially regulated? These are the topics discussed in the next two sections.
3.3.2 Corrections for multiple testing
Consider the situation where m genes are tested. Correspondingly, there will be
m p-values. For a given significance level α, genes having a p-value lower than
this value are judged as significantly differentially regulated. These genes are
termed the positive genes. The genes with p-values larger than α are termed
the negative genes. Among the positive genes, some are false positives (FP)
in the sense that they are judged as significantly differentially regulated but in
reality they are not. The rest of the positives are denoted the true positives
(TP). Similarly for the negative genes, some are truly negative (TN), and some
are false negatives (FN), that is, they are judged as being not differentially
regulated but in reality they are.
When thresholding m genes at significance level α, by the definition of the p-
value (the probability of incorrectly rejecting H0), we thus except the number of
FPs to be αm (this of course assumes that the genes are independent, which they
in reality are not exactly, because of the networks they interact within). If m is
large, αm FPs are usually far too many to include in the group of significantly
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differentially regulated genes. A simple correction for this is the Bonferroni
correction. Here, the p-value of each gene is multiplied by m (if it then exceeds
1, it is set to 1). This is the same as setting the significance threshold to α/m.
With this significance level the number of FPs is (α/m)×m = α. On the other
hand, in many situations this often prove to be too restrictive. Also, the number
of FNs is quite large when using this correction. More formally, the probability
of including at least one FP is called the family wise error rate (FWER), and
it is this rate that the Bonferroni correction controls at level α. Several other
corrections for multiple testing that control the FWER have been proposed,
for example the Sidak, Holm-Bonferroni, Holm-Sidak, Hochberg, and Westfall-
Young correction methods (Amaratunga and Cabrera, 2004). They differ by
their control over the expected number of FNs, as well as their handling of the
not-all-genes-are-independent issue. However, all the correction methods are
fairly restrictive, in the sense that the p-values have to be quite small in order
to be allowed among the positives.
Often, the main concern is preventing an inordinately large number of false posi-
tives from clouding the results. In this case, controlling the expected proportion
of FPs among all the positives, termed the false discovery rate (FDR) is what is
needed. Benjamini and Hochberg (1995) have proposed a step-up procedure for
controlling the FDR. Using this procedure, the p-values are adjusted as follows:
(1) Order the m p-values, p1 < p2 < . . . < pm. (2) For each of the p-values in
this ordering, adjust pi to mpi/i. By allowing only genes with adjusted p-values
less than α as the positive genes, the FDR is controlled at level α (Benjamini
and Hochberg, 1995). This procedure was later shown to also control the FDR
for many types of dependency among the tests (Benjamini and Yekutieli, 2001).
The above adjustment is actually a conservative one. In reality the adjustment
is mrpi/i where r is the fraction of true negative genes, r = TN/m. Various
approaches for estimating this fraction have been developed (Qian and Huang,
2005).
By controlling the FDR, one usually allows for many more positives than when
one controls the FWER. In general, specifically which rate to control and proce-
dure to use depends on what one wants to do with the list of positives generated.
For the research in this thesis we found that controlling the “classic” FDR pro-
posed by Benjamini and Hochberg (1995) gave excellent results in terms of bio-
logical significance of the list of positive genes. All tests that generate p-values
can be controlled with these methods, not just tests based on the F -statistic. For
the testing of overrepresented GO terms using Fisher’s exact test (see Sec. 4.1),
we found that controlling the FWER using the Bonferroni correction was ap-
propriate.
3.3.3 Assumptions
If enough replicates have been made, one can test that the expression measure-
ments of each gene are normally distributed using for example the Kolmogoroff-
Smirnoff test (Freund and Wilson, 2003). Also, the assumption of equal vari-
ances can be tested using the Hartley F -max test or the Levene test.
For microarray experiments, it is in general accepted that the variation among
replicates is roughly proportional to the mean, σ2k ∝ ak, and thus that a log-
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transformation can stabilize the variance. Usually, log2 is used since two-, four-,
eight-, etc.-fold upregulations are then easily identified as the differences 1, 2, 3,
etc. between log2-transformed numbers (and vice versa with negative differences
for downregulations). More detailed analysis has shown that for low expression
values specifically, it seems that the variance does not depend on the mean. That
is, at low expression values, replicate measurements are normally distributed and
do not need to be transformed (Durbin et al., 2002). In response to this, the
arcsinh function has been proposed as a variance stabilizing transformation that
handles both low, medium, and high expression levels correctly (Durbin et al.,
2002, Huber et al., 2002).
If the microarray data are very noise and with frequent outliers, or if one does
simply not trust, even after transformation, that the data fulfills the assumptions
of normality and equal variance, a non-parametric test can be used instead. Two
such tests are discussed in the following section.
3.3.4 Non-parametric tests
The non-parametric version of the t-test (two conditions compared) is theWilcoxon
rank-sum test (Freund and Wilson, 2003). There are two groups of intensities
we want to compare, and the test proceeds as follows: (1) Replace all intensities
with ranks according to their magnitude: 1 for the smallest, 2 for the second
smallest, and so on. (2) Next, calculate the sum of ranks in each group. (3)
From each sum subtract the theoretical minimum sum (in a group containing
one intensity the theoretical minimum sum is 1, in a group containing two in-
tensities it is 1 + 2 = 3, for three intensities it is 1 + 2+ 3 = 6, and so on). The
two differences are denoted W1 and W2 (subscript 1 for the first group and 2 for
the second group). (4) Based on W1 and W2 and the number of intensities in
each group, a p-value can be calculated. Here, the p-value is the probability that
the calculated W values could have occurred by chance. Therefore, the lower
the p-value, the more significantly different are the two groups of intensities.
The idea behind the Wilcoxon rank-sum test is extended to compare more than
two conditions in the Kruskal-Wallis test. This test is then the non-parametric
equivalent to a one-way ANOVA test.
In general, for the non-parametric tests, robustness and data-structure indepen-
dence is traded for significance. For a differentially regulated gene where the
assumptions are fulfilled, a t-test will usually result in a lower p-value than a
rank-sum test.
3.3.5 Modifying the F-statistic when multiple testing
The testing of hundreds or thousands of genes imposes the need for carefully
selecting or adjusting p-values as discussed in Sec. 3.3.2. However, besides the
need for correcting the p-values due to multiple testing, one can take advantage
of the multiple tests performed when calculating the test statistic. For example,
all the variances calculated for all genes can be used to estimate the distribution
of these. And this variance distribution can be used to identify outlier variances
(too large or too small variances) and correct them (by appropriately shrinking
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or expanding them). Different empirical Bayes approaches to this have been
suggested (Baldi and Long, 2001, Smyth, 2004).
3.3.6 Research example: Detection and validation of genes
responding to pathogen interaction (paper I)
Detection
Differential expression between infected and/or resistant samples compared to
control samples was assessed using the R software package LIMMA (Gentle-
man et al., 2004, Smyth, 2004, 2005). This package implements a multivariate
statistical method that uses all nine arrays simultaneously to judge statistical
significance (as described in Sec. 3.3.5). Briefly, for each gene, empirical Bayes
moderated F -statistics were used to test for changes between infected and/or
resistant samples compared to control samples. Genes were considered signifi-
cantly regulated if the p-values, adjusted for multiple testing (Benjamini and
Hochberg, 1995), were < 0.05. The false discovery rate (FDR) was thus limited
to less than 5%. Using this method, 332 genes were found to be significantly
regulated upon powdery mildew attack.
The expression profiles of the 332 candidate genes are shown in a heatmap
in Fig. 3.2A, and ordered according to their regulation in a Venn diagram in
Fig. 3.2B. The Venn diagram shows that 46 genes were upregulated only in sam-
ples from infected cells, 98 genes were upregulated only in resistant cell samples,
and 54 genes were upregulated in both infected and resistant cell samples. The
numbers of downregulated genes were consistently smaller. Here, 22 genes were
downregulated only in infected cells, 73 genes were downregulated only in re-
sistant cells, and 40 genes were downregulated in both infected and resistant
cells. No genes were found to be regulated in opposite directions in infected and
resistant cells. Thus, our data suggest that in general, if a gene is affected in
both types of cells, it is regulated in the same direction. Notice also that on
the 10k-array more genes were regulated in resistant cells (265 genes) than in
infected cells (162 genes).
Validation
Direct confirmation of all candidate gene expressions in individual resistant and
infected cells by e.g. in situ hybridization or single-cell real-time PCR would be
extremely laborious, and, crucially, carry implicit dangers of artefactual effects.
An alternative is to compare candidate gene expressions with expression data
obtained using RNA bulked from dissected epidermal tissue or whole leaves from
similar barley/powdery mildew interactions. Such data are not as specific as
single-cell data. However, since no genes were found to be regulated in opposite
directions in infected and resistant cells, we expect that most genes, if detectable,
are regulated in the same direction in single cell and bulk sample extracts. Also,
most importantly, use of bulk sample extracts avoids potential artefactual ef-
fects on transcript abundance that may be introduced during amplification of
mRNA from very small amounts. Thus, comparison with bulk sample extracts
would serve not only to validate data for directed regulation of our candidate
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Figure 3.2: The candidate genes and their regulation. (A)
Heatmap of the 332 most significantly (FDR < 0.05) differen-
tially expressed genes. The dark red colour signifies high expres-
sion whereas the deep blue colour signifies low expression relative
to the general expression of each gene. Each column represents a
sample and each row represents all expressions for a given candi-
date gene. The differential expression pattern is clearly seen and
can be divided into 6 main patterns of regulation (indicated by the
colorbar to the right of the heatmap). (B) Venn diagram group-
ing the candidate genes according to the 6 regulation types. The
numbers in each part of the Venn diagram represents the number
of genes with the given type of regulation. C: Control sample, R:
Resistant sample and I: Infected sample.
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Figure 3.3: (A) Dissected epidermal tissue (10k-array). (B) Whole
leaf material (Affymetrix Barley Genome Array).
genes, but would also validate the single-cell analysis approach in general. Con-
sequently, we compared our single-cell data with bulk sample results obtained
independently using the 10k-array, the Affymetrix Barley Genome Array, and
RT-PCR tests for 10 selected genes.
For comparison with the 10k-array, we considered data obtained using dissected
epidermal tissue from an unpublished larger experiment performed at the Gater-
sleben laboratory, Germany (Axel Himmelbach and Patrick Schweizer, person-
nel communication). Here, the epidermal tissue was sampled at 24 hours after
inoculation (hai) whereas our single cell study extracts were made at 18 hai.
Taking the ratio of mean gene expression from inoculated compared to non-
inoculated material (four replicates of each) provided regulation data that could
be compared to the single-cell data. This analysis confirmed the regulation of
287 out of 332 of our candidate genes, i.e. a confirmation rate of 86% (see
Fig. 3.3A for details).
Whole leaf data was available from a time-course study performed by Caldo
et al. (2004) using the Affymetrix Barley Genome Array. Using BLASTN we
determined the probesets on the Affymetrix array corresponding to the candi-
date genes on the 10k-array. For these probesets, we then determined which
were significantly differentially expressed (using a t-test with p-values corrected
for multiple testing FDR < 0.05) between non-inoculated and inoculated whole
leaf material extracted at 20 hai. The results are shown in Fig. 3.3B. Out of the
54% of the candidate genes that were significantly regulated, 77% confirmed the
regulation found in our single cell study. For these, 90% were also confirmed by
the 10k-array data so the confirmed regulations are highly overlapping.
We consider that confirmation rates of 77-86% are sufficiently high to impart
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confidence in the regulatory information derived from single cell analyses. This
is underlined by the fact that the comparisons were derived: (1) from differ-
ent laboratories and array platforms and with somewhat different experimental
protocols; (2) using RNA bulked from epidermal tissues as well as whole leaves;
(3) using slightly different time-points during the interaction; and (4) with dif-
ferent genotypes of barley and powdery mildew fungus. Also, some of the gene
regulations that could not be confirmed in bulk extracts could be due to the
fact that differential expression of many genes can only be detected in single
cell material and not in bulk samples (Gjetting et al., 2004).
To further confirm the observed regulation of the candidate genes, we per-
formed a simple RT-PCR test for 10 of these that are predominantly known
to be pathogenesis-related genes. Expressions of these genes were tested in to-
tal RNA from powdery mildew-inoculated or uninoculated barley leaf material
that was harvested 18 hai. The results confirmed the upregulation of seven and
downregulation of two out of three of the genes, i.e. a confirmation rate of 90%.
3.3.7 Clustering and classification
Testing for differential regulation is only one of a plethora of techniques used
to analyze different aspects of microarray data. Another much used analysis
approach is to investigate relationships between genes or samples. The grouping
of genes or samples based on a measure of similarity is known as clustering.
Here, the superparamagnetic clustering (SPC) algorithm will be described (Blatt
et al., 1996) since that algorithm is used in the example in Sec. 3.3.8 below.
The SPC algorithm can be understood by an analogy to physics: as a parameter
T (the temperature) is increased, the system undergoes phase transitions (for
example, it melts). In our case, T is increased from 0 (all objects form one
cluster) to Tmax (each object forms a separate cluster). The breakup of larger
clusters into smaller subclusters is governed by the structure of the data: similar
objects tend to stay together over a large increase in T , whereas less similar
objects break apart more easily. The range of T s for which a given cluster
remains unchanged, denoted by ∆T , is used as a stability measure for the cluster.
As the measure of similarity between objects, the Euclidean distance is used for
both samples and genes. Because the gene expressions are first row-centered
and normalized before being clustered, their squared distance is proportional to
1− r, where r is the correlation coefficient. The correlation coefficient captures
similarity in shape and the Euclidean distance captures similarity in magnitude.
3.3.8 Research example: Selection of antigen repertoires
(paper III)
To ease the following discussion, the experimental protocol is briefly summarized
in Fig. 3.4. The numbers in the figure refer to the age (in weeks) of the mice.
The black vertical lines at 4 and 9 weeks indicate serum sample collection. The
grey vertical lines at 4 and 5 weeks indicate cyclophosphamide injection. The
grey box at 6 weeks shows when the CAD-susceptible mice developed diabetes,
and the grey box between 11 and 13 weeks shows the time of death of the un-
treated diabetic mice. In the following, samples taken before cyclophosphamide
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Figure 3.4: The experimental protocol.
injection are indicated by a “B” (before), and samples taken after by an “A”
(after). Further, samples from mice that develops diabetes are also indicated by
a “S” (sick), and samples from mice that do not develop diabetes are indicated
by a “H” (healthy). Thus, there are four sample types: HB, SB, HA, and SA.
Data analysis
To determine subsets of the 266 antigens that would separate the sick and
healthy mice, we used the Wilcoxon rank-sum test. This test is non-parametric
and therefore robust to outliers. We test one antigen at a time, replacing the re-
activities (or ratios) with ranks according to their magnitude: 1 for the smallest,
2 for the second smallest, and so on. The p-values found by using this method
were all larger than 0.01; therefore, no single antigen was found to significantly
discriminate between the two groups when controlling the FWER (Bonferroni
correction) or the FDR (Benjamini and Hochberg, 1995). This finding signifies
that the signal produced by any single antigen is unable to separate the sick mice
from the healthy. Separability might be achieved, if at all, by using reactivity
(or ratio) profiles defined over several antigens.
To capture a collective effect of several antigens, we selected the 27 antigens (10%
of the 266 antigens in the study) with the lowest p-values, and investigated how
good they were collectively at separating sick from healthy mice, and which of
them showed correlated behavior over the samples, by applying two-way SPC.
This algorithm gives an unsupervised clustering of the subset of antigens and
of the samples, and provides an inherent mechanism for identifying robust and
stable clusters in the form of the parameter ∆T . The clusters of samples found
by using this method were thus evaluated for their stability ∆T , specificity,
and sensitivity. Specificity is the proportion of sick mice in the “sick cluster”,
sensitivity is the proportion of the sick mice in the sick cluster compared with
all of the sick mice in the study.
Statistical significance
To obtain a measure of the significance of the separation between sick and
healthy mice by using the method outlined above, we performed the following
test: From the group of healthy mice, we picked five of the samples at random,
and similarly, for the group of sick mice, we randomly picked four of the sam-
ples. These nine samples were labelled as “type 1” The remaining samples were
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labelled as “type 1” We hypothesized that there should be no clear separation
between these randomized types: we used the Wilcoxon rank-sum test to iden-
tify the 27 antigens that differentiated best groups 1 and 2. Next, we clustered
the mice in the space of these 27 antigens, and looked for stable, specific, and
sensitive clusters, by using SPC. We performed the test 1000 times on different
randomized groups and recorded the stability, specificity, and sensitivity of the
resulting clusters. The proportion of random clusters manifesting these features
to the same or to a better degree than the actual cluster establishes the p-value
of the actual cluster.
Selection of informative antigens for pre-CAD mice
Based on the sera taken before cyclophosphamide treatment, the 27 antigens
that separated best between the sera of the 10 mice that later resisted the in-
duction of CAD (HB), and of the 9 mice that later developed CAD (SB) (by
using the Wilcoxon rank-sum test and taking the 10% with lowest p-values, as
described above), were determined. Figure 3.5A shows the two-way SPC of
these antigens. The mice susceptible to future CAD induction are denoted by
the filled rectangles at the top of the clustering box; the mice resistant to future
CAD induction are denoted by the empty rectangles. The 27 antigens are clus-
tered at the rows and are identified by number (refer to Table 1 in paper III). It
can be seen that all 9 mice that were found later to be susceptible to CAD could
be separated from 8 of the 10 mice that were later found to resist CAD. Before
cyclophosphamide, the CAD-susceptible mice manifested relatively elevated IgG
reactivity to the top 19 antigens in Fig. 3.5A, whereas the CAD-resistant mice
manifested relatively elevated IgG reactivity to the remaining eight antigens.
The clustering separation was significant (p = 0.017; only 17 of 1000 randomly
generated groups showed results comparable with the actual data set). Thus,
mice susceptible to CAD could be distinguished by their patterns of IgG serum
antibodies from mice resistant to CAD, even before cyclophosphamide was ad-
ministered to the mice.
Selection of informative antigens for post-CAD mice
We then used the 27 antigens effective in pre-CAD clustering to analyze the
patterns of IgG antibodies developing in the diabetic and healthy mice post-
CAD. Surprisingly, these 27 antigens failed to discriminate between the two
groups of mice; the obvious pre-CAD clusters seen in Fig. 3.5A dispersed when
the same antigens were used to cluster the post-CAD sera; compare Fig. 3.5A
and B. For this reason, we tested whether other sets of antigens might be more
informative post-CAD.
The 27 antigens that best separates the reactivities measured post-CAD (HA
versus SA) are shown in Fig. 3.6A. Also, a third set of 27 antigens was generated
by performing the Wilcoxon rank-sum test on the ratios by which each anti-
gen changed post-CAD/pre-CAD. The ratios provide information on reactivity
changes toward the antigen. These are shown in Fig. 3.6B. It is seen that these
two sets of antigens could indeed separate between the healthy and diabetic mice
post-CAD: specificity up to 82% and sensitivity up to 100% (p = 0.065). Thus,
the IgG repertoires of the pre- and post-CAD groups of healthy and sick mice
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Figure 3.5: Reactivity matrices of 27 antigens that separate dia-
betic and healthy mice. The rows are antigens and the columns are
the mouse sera. Each antigen is identified by the number between
the two reactivity matrices (see Table 1, paper III). The Left Panel
(A) shows a two-way SPC of the 27 top-ranking antigens from the
SB versus HB comparison. The length of a branch connecting to a
cluster represents the stability of the cluster. Filled boxes denote
mice that later developed CAD, and open boxes denote mice that
resisted CAD. The Right Panel (B) shows the SPC of the same
antigens, but using the reactivities from the post-CAD samples
(SA and HA). Filled boxes denote mice that developed CAD, and
open boxes denote healthy mice that resisted CAD.
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Figure 3.6: (A) Two-way SPC of the 27 antigens (numbered)
that best separate SA and HA mice, done applying the Wilcoxon
rank-sum test to the reactivities. Filled boxes denote diabetic
mice and open boxes denote healthy mice. (B) Two-way SPC
of the 27 antigens (numbered) that best separate the sick and
healthy mouse samples, done applying the Wilcoxon rank-sum
test to the pre-CAD and post-CAD ratios. Filled boxes denote
mice susceptible to CAD and open boxes denote mice resistant to
CAD.
could be clustered, but the informative patterns of reactivity required modified
sets of antigens to develop discriminating patterns. It can be seen that some
of the antigens from the set of pre-CAD antigens were also present in the post-
CAD set, or in the set of antigens determined from the pre-CAD/post-CAD
ratios. For example, three of the pre-CAD antigen reactivities were also promi-
nent post-CAD (antigens 17, 18, and 26). The shared and distinct antigens are
shown as a Venn diagram in Fig. 3.7. The group S versus H (ratio difference)
can be seen to have generated a set of antigens most shared (dark rectangles)
between pre-CAD sera (HB versus SB) and post-CAD sera (HA versus SA).
3.4 Geometric interpretation of least squares fitting
In paper IV, least squares fitting is applied in three situations. The first one
being when the binding constants of NADH to several proteins needs to be
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Figure 3.7: Venn diagram showing antigens that were unique to
each set or shared by any of the three groups of 27 antigens that
best separated the groups of mice.
determined using isothermal titration calorimetry (ITC). This situation will
not be discussed here since it is well established (Leavitt and Freire, 2001) and
even implemented in a software package that comes with the ITC apparatus.
The second being the fitting of the model developed for the homeostasis of free
and bound NADH to data (discussed in Sec. 3.5.2). And the third, which is
treated in Sec. 3.4.1, being the determination of the spectrum of bound NADH
and its subsequent use in estimating the amounts of free and bound NADH in
mitochondria. To prepare for this, the geometric interpretation of least squares
fitting is introduced below.
As a simple example, take the model
f = a1xi + a2yi i = 1, . . . , N (3.3)
To make the geometric interpretation more interesting there are now two in-
dependent variables (xi, yi) for each dependent variable zi (compared to the
models introduced in Sec. 3.1 which only had one independent variable). In
matrix/vector representation, (3.3) loosely becomes
z1
z2
z3
...
zN
 =

x1 y1
x2 y2
x3 y3
...
...
xN yN

(
a1
a2
)
written simply as
z = Xa (3.4)
where the equality sign is used in the sense that the right side is fitted to the
left side. Let the columns of X span the subspace X. The vector z and the
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Figure 3.8: Geometric representation of the estimation of a.
subspace X is shown in Fig. 3.8. Since all fits of the model in (3.3) to the data in
z must lie in the subspace X, it is intuitively clear that the vector in X closest
to z is the projection of z onto the subspace X, denoted projX(z) (also shown
in Fig. 3.8).
That projX(z) is the vector in X that is closest, in the least squares sense, to z,
can be seen from the following argument (adapted from Messer (1994)): Let s
be a vector in X. The distance between z and s can be written ‖z − s‖, where
the vertical double bars denote the norm. We need to determine the s that
minimizes this distance. First, write z − s = (z − projX(z)) + (projX(z)− s).
Since projX(z) and s are in the subspace X, so is projX(z) − s. Since z −
projX(z) is orthogonal to every vector in X, it is orthogonal to projX(z)−s. By
the Pythagorean Theorem, we can therefore write ‖z−s‖2 = ‖z−projX(z)‖2+
‖projX(z) − s‖2. The first term in this sum is not affected by our choice of s.
Inspection of the second term shows that the minimum value of the sum occurs
when s = projX(z), making this terms zero. That is, by choosing s = projX(z),
the difference ‖z − s‖2, and therefore also the difference ‖z − s‖, is minimized.
The connection between ‖z− s‖2 and χ2 becomes clear if the former is written
explicitly (compare with (3.2))
‖z − s‖2 =
N∑
i=1
(zi − si)2
Finally, by projecting projX(yz) onto each of the columns in X, the parameters
a1 and a2 are determined.
Using the geometric approach, these projections can be written compactly as
follows. First, multiply each side of (3.4) by the transpose of X
XTz = XTXa
end then by the inverse of XTX
(XTX)−1XTz = (XTX)−1XTXa
By the definition of the inverse of a matrix we can now write
a = (XTX)−1XTz (3.5)
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where (XTX)−1XT is denoted the pseudoinverse of X. Consequently, the pseu-
doinverse provides a least squares solution to (3.4) (Penrose, 1956). Finally,
multiplying with X on both sides of (3.5) gives
projX(z) = X(X
TX)−1XTz
Having determined the parameters that minimizes χ2 in this manner, the dif-
ference between the model and the data, z − projX(z), is denoted the residual,
r (shown in Fig. 3.8). The length, ‖r‖, of which gives an estimate of the quality
of the fit.
3.4.1 Research example: Spectral decomposition (paper IV)
The spectrum of free NADH can be directly measured. The spectrum of bound
NADH not so. When adding both protein (that binds NADH) and NADH to
solution, there will always be a proportion of NADH that is not bound due to the
reversibility of the binding process. In the limiting case where large amounts
of protein is added to a solution containing only small amounts of NADH,
thus making the amount of free NADH very small, the emmision spectrum of
free NADH is difficult to detect due to its scarcity. Even if the spectrum is
detectable, the system is far from in vivo conditions which makes the relevance
of the measured spectra doubtful.
Consequently, in order to determine the spectrum of bound NADH, a model
that predicts the combined spectrum of both free and bound NADH is needed.
We base the model on the notion that an experimental emission spectrum can
be written simply as a linear superposition of the emission spectra of free and
bound NADH. Specifically, spectra are nonnegative functions of frequency on
the experimentally accessible frequency interval. Squared-integrable real func-
tions on this interval form a vector space. The emission spectra of free and
bound NAD(P)H are two linearly independent vectors in this space. The ex-
perimental emission spectrum is a third vector in the same space and lies in the
two-dimensional subspace spanned by the first two vectors if the experimental
emission spectrum originates in free and bound NADH. In practice, we repre-
sented the spectra by their values at 1100 frequency values. Then, a vector in
the abstract function space is represented by an ordinary vector with 1100 real
elements, and decomposition becomes matrix algebra: Emission spectra of the
species free NADH and NADH bound to ADH (arranged in an 1100× 2 matrix
B) were calculated from emission spectra of n standard mixtures of NADH and
ADH (in a 1100 × n matrix S) using the 2 × n matrix C of the NADH species
concentrations in the standard mixtures as follows. Ideally,
S = BC
Which rearranges to
B = SCT(CCT)−1 (3.6)
The standard mixtures used for this calculation are shown in Table 3.1, and
their fluorescence spectra in Fig. 3.9A. Specifically, the mixtures 6, 7, and 8
were used in the calculation presented above.
Using the spectra for free and bound NADH thus derived and stored in B (see
Fig. 3.9B), the decomposition of experimental emission spectra from solutions
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Table 3.1: Calculated concentrations of different NADH species
in calibration runs. Concentrations of the stock solutions were
determined spectrophotometrically. Measurements were done in
a stirred open Rank oxygraph vessel at a solution volume of 0.75
ml.
Mixture [NADH] [ENADH] [E]
(µM) (µM) (µM)
1 0 - -
2 2.22 - -
3 4.40 - -
4 6.54 - -
5 0 0 16.28
6 1.27 0.95 15.20
7 2.58 1.82 14.20
8 3.92 2.62 13.27
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Figure 3.9: Decomposition of standard spectra into free and bound
NADH. (A) Pseudo steady-state emission spectra of mixtures of
NADH and ADH in 5mM HEPES pH 7.5 (the exact compositions
are given in Table 3.1). (B) The base spectra of free and bound
NADH used in the further decomposition of fluorescence spectra
of potato tuber mitochondria.
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containing isolated mitochondria proceeds as follows. Let the matrix Z contain
a series of m experimental emission spectra (1100 × m). The concentrations
of free and bound NADH in each experiment in this series (represented by the
2×m matrix D) multiplied by the emission spectra of free and bound NADH,
B, should yield Z.
Z = BD
In a manner similar to above, by taking the pseudoinverse of B, we get
D = (BTB)−1BTZ (3.7)
This decomposition of experimental spectra in Z after the two spectra in B is
equivalent with least squares fitting of a linear superposition of the two spectra
in B to each of the spectra in Z, as discussed in Sec. 3.4. The parameters fitted
are the elements of D, and their resulting values are those given in the identity
for D above. The quality of the fit can be evaluated by inspection of the residual
spectra arranged in the 1100×m matrix R as follows
R = Z− BD
In Fig. 3.10A are shown four experimental spectra (triangles) along with least
squares fit of linear superpositions of free and bound NADH (lines). In Fig. 3.10B
are shown the residuals for each fit. Notice that the residuals have the same size,
no matter the spectrum. This indicates the presence of an additional component
which is not dependent on the amounts of free and bound NADH. This could
for example be the mitochondria themselves, or simply scattered light from the
excitation source.
3.5 Nonlinear models
Nonlinear models are models that result in equations that are not linear in
the parameters. For such models, the minimization of χ2 does not yield a set
of coupled equations that are linear in the parameters, and consequently, an
analytical solution usually does not exist. Therefore, approximation methods
that searches the χ2 hypersurface to find sets of parameters at local minima are
used instead. The generality of such approximation methods also allow models
defined by differential equations which have no analytical solution to be fitted
to data in this manner. In this case, the fitting algorithm is coupled to the
numerical integration of the differential equations.
For interaction networks where the rate equations are known, the network can
be modelled by differential equations. Such a network could for example be a
metabolic pathway where the workings of each enzyme is specified by a rate
equation. The differential equations of such models can not usually be solved
analytically, and if they can, the solution is often nonlinear. Another aspect
of such models is that usually, the number of parameters that need to be fit-
ted are quite large. For example, for modeling the turnover of NADH in plant
mitochondria, Hagedorn et al. (2004) used a network of 7 enzymes and pro-
teins interacting with 14 metabolites. For this relatively simple network, there
were 34 parameters that needed to be constrained, specified, or fitted (enzyme
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Figure 3.10: (A) Fluorescence spectra from selected time points.
Triangles are experimental data, lines are fits. (B) Residuals for
the fits shown in A. POM: Mitochondria without substrate or
ADP added. Malate: Mitochondria with malate added. State
3: Mitochondria with substrate and ADP added. State 4: Mi-
tochondria with substrate and ADP added, but where ADP has
been converted to ATP (see Sec. 3.5.2)
parameters, total metabolite concentrations, addition times, etc.). For models
with that many parameters, an immediate concern is that it can be fitted to
anything. Ensemble methods that attempt to formalize how such models should
be explored and fitted have been developed (Battogtokh et al., 2002, Brown and
Sethna, 2003). Another approach that circumvents part of the problem is to
focus on the steady-state solution to the model equations, and then expand that
solution to the immediate dynamic neighborhood using a nonlinear dynamics
framework (Danø et al., 1999).
Several approximation methods have been developed to search the parameter
space, for example the Grid Search Method, the Gradient Search Method, and
various expansion methods that linearize the fitting function (Bevington and
Robinson, 2004). A method that combines these methods is the Levenberg-
Marquardt algorithm (Press et al., 1997), which is described in the next section.
In Sec. 3.5.2, an example of a simple steady state model of NADH homeostasis
is presented and fitted to data using an implementation of this algorithm.
3.5.1 The Levenberg-Marquardt method
For simplicity, let a be a vector containing the parameters of the model. The
χ2 can then be written
χ2 ≡
N∑
i=1
(
ci − yi(a)
σi
)2
(3.8)
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(compare with (3.2) in Sec. 3.2). Differentiating (3.8) with respect to a gives a
set of equations which must hold at the chi-square minimum
∂χ2
∂ak
= −2
N∑
i=1
(
ci − yi(a)
σ2i
)(
∂yi(a)
∂ak
)
= 0, k = 1, . . . ,M (3.9)
By the Levenberg-Marquardt method, the solution to the set of equations (3.9),
proceeds iteratively as follows.
The a at the minimum is denoted amin. For an a sufficiently close to amin,
denoted acur, it is expected that the χ2 function (3.8), is well approximated by
the quadratic form
χ2(amin) ≈ χ2(acur) +
∑
i
∂(χ2)
∂ai
adiff,i +
1
2
∑
i,j
∂2(χ2)
∂ai∂aj
adiff,iadiff,j
= χ2(acur) + adiff · ∇χ2(acur) + 12adiff ·D · adiff (3.10)
where adiff = amin − acur and D is an M ×M matrix. Since ∇χ2(amin) = 0,
from (3.10)
amin = acurr +D−1 · [−∇χ2(acurr)] (3.11)
When a is not close to the minimum, or if (3.10) is not a good local approxi-
mation, the best thing to do is to take a step down the steepest gradient
anext = acurr − constant×∇χ2(acurr) (3.12)
where the constant is chosen small enough not to extrapolate the information
from ∇χ2(acurr) too far away.
In brief, the Levenberg-Marquardt method provides a way to change continu-
ously between (3.11) and (3.12), simply by varying a parameter λ: For λ = 0,
equation (3.11) is used solely, and for λÀ 1 equation (3.12) is used solely. For
intermediate values of λ, a combination of (3.11) and (3.12) is used.
The method as implemented by Press et al. (1997) then consists of the following
steps
(1) Compute χ2(acurr).
(2) Based on the value for λ, find a new value for a, called anext.
(3) If χ2(anext) ≤ χ2(acurr), decrease λ by a factor of 10. If χ2(anext) >
χ2(acurr), increase λ by a factor of 10.
(4) Set acurr to the value of anext, and go back to (1).
The fitting stops if no better value for a has been found in 10 consecutive steps,
or if a new value for a has only improved |χ2(anext)−χ2(acurr)| by a negligible
amount (< 10−3), in 5 consecutive steps. Once an acceptable minimum has
been found, the M ×M matrix C = (1/2)D−1, evaluated at amin, provides an
estimate for the covariances of a.
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The diagonal entries of the covariance matrix C are the squared uncertainties
associated with a, therefore
σ(aj) =
√
Cjj
From the off-diagonal elements of C, the correlation between elements of a can
be determined
r(aij) =
Cij
σ(ai)σ(aj)
3.5.2 Research example: Modeling NADH homeostasis
(paper IV)
When glutamate and malate are added to a solution containing mitochondria,
they are transported into the mitochondria and oxidized by enzymes like gluta-
mate dehydrogenase, malic enzyme, and malate dehydrogenase. The oxidation
of substrates by these enzymes is coupled to the reduction of NAD+ to NADH.
The two entry-point electron transport chain (ETC) enzymes complex I and
NDin then reoxidize NADH to NAD+, and passes the electrons gained along to
the enzymes of the ETC. During this transport the electrons participate in a se-
ries of oxidation/reduction reactions before they are finally used by cytochrome
c oxidase to reduce O2 to H2O. The oxidation/reduction reactions are coupled
to the active pumping of protons out of the matrix, and this establishes an elec-
trochemical potential over the inner membrane. This potential is used by ATP
synthase to phosphorylate ADP to ATP, be letting 3 to 4 protons flow back
into the mitochondrial matrix for each ADP phosphorylated. The production
of ATP by the oxidation of substrates, as described here, is called oxidative
phosphorylation.
Concerning the turnover rate of NADH during oxidative phosphorylation: When
ATP synthase is active and allow protons to flow into the matrix, the membrane
potential is smaller, and it is easier for the ETC enzymes to pump protons
out again. That is, the ETC enzymes can work faster when ATP synthase is
active. Therefore, when ADP is present and ATP synthase therefore is active,
the turnover of NADH by complex I and NDin is higher (much higher in fact)
than when ATP synthase is not active. When ADP (and substrate) is present,
the mitochondria are said to be in state 3, and when ADP is depleted, the
mitochondria are in state 4.
In Fig. 3.11 is shown the relative concentrations of total, free, and bound NADH
as a function of time. At each time point, these relative concentrations were cal-
culated by decomposing the experimentally measured spectrum onto the spectra
of free and bound NADH as discussed in Sec. 3.4.1. As is seen, the amount of
free NADH is relatively constant, perhaps displaying a slight increase when
ADP is added (state 3) compared to when ADP is depleted (state 4). Since the
NADH turnover rate is much higher in state 3 compare to state 4, as discussed
above, we expect that there is less NADH present in mitochondria in state 3
compared to state 4. For the amount of bound NADH, this is also the case.
However, as seen, the amount of free NADH is constant or even increasing a
little in state 3. This indicates that there might be a mechanism which keeps
the concentration of free NADH approximately constant.
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Figure 3.11: Amounts in arbitrary units of free, bound, and total
NADH obtained by decomposition of the fluorescence spectra.
We have attempted to explain this phenomenon by modeling the binding of
NADH and NAD+ to mitochondrial proteins in state 3 and 4. Since the amount
of experimental data is limited, the model needs to be kept simple in order to
avoid having too many unknown parameters, as discussed in the beginning of
Sec. 3.5. We proceed as follows.
It is assumed that NADH and NAD+ bind reversibly to the same pool of binding
sites, E, that is
E + NADH −−⇀↽− ENADH (3.13a)
E + NAD+ −−⇀↽− ENAD+ (3.13b)
where ENADH and ENAD+ denote the bound NADH and bound NAD+ re-
spectively. In the matrix, NADH is converted to NAD+ by Complex I and
NDin, and NAD+ is converted back to NADH by (primarily) malic enzyme and
malate dehydrogenase. We need not consider the details of these enzymatic
reactions if we simply assume that the system has reached a steady state (no
change in concentration over time at the time points considered). Consequently,
the conversions are written simply as
NADH −−⇀↽− NAD+ (3.13c)
At steady state, Reactions (3.13a–3.13c) can be written as the following equi-
libriums
KNADH =
[ENADH]
[E][NADH]
(3.14a)
KNAD+ =
[ENAD+]
[E][NAD+]
(3.14b)
KC =
[NAD+]
[NADH]
(3.14c)
where the brackets around the compounds denote equilibrium concentrations,
and KNADH, KNAD+ , and KC are the equilibrium constants. Also, reactions
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(3.13a–3.13c) imply that the total concentration of binding sites (e) and the
total concentration of NAD(H) (n) are constant
[E] + [ENADH] + [ENAD+] = e (3.14d)
[NADH] + [NAD+] + [ENADH] + [ENAD+] = n (3.14e)
Equations (3.14a–3.14e) constitute five equations, with five parameters (KNADH,
KNAD+ ,KC, e, and n) and five concentrations ([NADH], [NAD+], [E], [ENADH],
and [ENAD+]).
Combination of (3.14a–3.14e) yields the equations from which [NADH] (or [E])
can be calculated. First
e = [E]
(
1 +K[NADH]
)
(3.15)
n = [NADH]
(
L+K[E]
)
(3.16)
with
K = KNADH +KCKNAD+ (3.17)
L = 1 +KC (3.18)
The solution for [NADH] can then be written
[NADH] =
−(L+K(e− n))+√(L+K(e− n))2 + 4nKL
2KL
and the other concentrations follow from this.
Next, to obtain values for the parameters, the model needs to be compared
to the experimental data. Steady state relative concentrations of free, bound,
and total NADH were estimated from Fig. 3.11. Total amounts of NADH and
NAD+ were measured by extraction. The estimated relative concentration of
total NADH was compared with the measurement of extracted total NADH,
and using this comparison, relative concentrations of free and bound NADH
were converted to absolute concentrations accordingly. These concentrations
are given in Table 3.2.
Assuming that states 3 and 4 are both in steady state, we wish to determine
sets of parameters for each state that reproduce the data in Table 3.2 — the
most interesting aspect being the slight increase in the amount of free NADH
from state 4 to state 3.
There are five parameters: n, e, KC, KNADH, KNAD+ . The extractions show
that the total concentration of NAD(H) (n) does not change between states.
Likewise, the total concentration of proteins binding NAD(H) (i.e., the total
number of binding sites e), is also constant, whereas the binding strength may
vary (see below). The parameter KC represents a combination of a number of
enzyme reactions, some of which are known to change between states 3 and
4 (e.g., complex I; Hagedorn et al. (2004)). A reasonable value for KC, or
an estimate of how it changes between states 3 and 4, is not easily inferred.
Consequently, in the following, we do not constrain this parameter between
states.
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Table 3.2: Total amounts of NADH and NAD+ were measured
by extraction. The values used are specifically those for the same
mitochondrial preparation used in Fig. 3.11. The measurement of
total NADH was used to convert free, bound, and total NADH
as estimated from Fig. 3.11 (state 3, 190 s; state 4, 420 s) from
relative concentrations to micromolar in the matrix (1mg mito-
chondrial protein is assumed to have 1µL matrix volume).
Compound State 3 State 4
(µM) (µM)
[NADH] 82 62
[ENADH] 82 160
[NADH+ ENADH] 160 220
[NAD+ + ENAD+] 730 640
This leaves us with KNADH and KNAD+ . For these two parameters, the three
simplest cases are considered: (1) both KNADH and KNAD+ are unchanged
between states 3 and 4, (2) only KNADH is changed, or (3) only KNAD+ is
changed. For each case, n = 875µM (calculated as the average total NAD(H)
in Table 3.2), and we explore a range of values for e (between 200 and 7000µM).
Using these values, the model is least-squares fitted to the data in Table 3.2 using
an implementation of the Levenberg-Marquardt algorithm (see Sec. 3.5.1). A
fit is considered as reproducing the data in Table 3.2 when χ2 < 1.
In case 1, keeping both KNADH and KNAD+ constant, it was not possible to
reproduce the data. Thus, it is only possible to model the results in Fig. 3.11
by changing the binding properties of NAD(H). In case 2, choosing an invari-
able medium binding strength (KNAD+ = 400M−1) similar to that determined
previously (Hagedorn et al., 2004, Blinova et al., 2005) and varying KNADH, the
data in Table 3.2 were easily reproduced. The values for KNADH determined by
this fit are shown in Fig. 3.12A. The ratio, KNADH(4)/KNADH(3), lies between
2.5 and 3, as seen in Fig. 3.12B. The absolute value of KNADH depends on the
total concentration of binding sites (which is unknown), but in general, a 2.5-
to 3-fold reduction of the binding constant in state 3 reproduces the data in Ta-
ble 3.2. In case 3, the data in Table 3.2 were not reproduced by any reasonable
constant value for KNADH (range tested: 10−4 to 106M−1).
Thus, we conclude that a change in the binding properties of NAD+, cannot
account for the experimental results. However, the data can by reproduced by
changing the average binding of NADH to proteins in the matrix and on the
inner surface of the inner mitochondrial membrane. Specifically, we estimated
that KNADH should decrease 2.5 to 3 times in state 3 compared with state 4.
3.6 Stochastic models
In Secs. 3.6.1 and 3.6.2, the basic theory concerning stochastic modeling of
random walks is introduced. This is followed by an example on how such models
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can be used for real data in Sec. 3.6.3.
Notation for this section: Expectation (or mean) values are denoted by brackets,
for example, the expectation value for η(t) is given by 〈η(t) 〉. The covariance
matrix of η is denoted by V(η(t) ) and the variance by σ2(η(t) ). The symbol
⊗ is the outer product, for example(
1
2
)
⊗
(
3
4
)
=
[
3 4
6 8
]
Matrices are in sans serif, V, and I is the identity matrix. Also, δ(t) is the Dirac
delta function.
3.6.1 The random walk
Noise
The white noise η(t) is an uncorrelated stochastic vector with vanishing expec-
tation value, that is
〈η(t)⊗ η(t′) 〉 = I δ(t− t′) ∀ t, t′ (3.19)
〈η(t) 〉 = 0 ∀ t (3.20)
We use the vector notation for the random noise since we will be dealing with
random noise in more than one dimension. Equation (3.19) in the definition
describes that the random noise is uncorrelated in both time and direction.
That is, since the expectation value of two different vector components of the
random noise multiplied with each other is always zero, the fluctuation in one
direction has no influence on the fluctuation in any other direction. And since
the expectation value of the random noise at time t multiplied by the random
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noise at time t′ is always zero, unless t = t′, the noise is uncorrelated in time (the
fluctuation a short while ago does not affect the fluctuation now). Basically, the
noise has no memory and does not know what each part of it is doing. Equation
(3.20) in the definition tells that the expectation value of all components and
at all times is equal to zero. That is, the noise fluctuates around zero. This is
clearly expected of something we describe as noise.
The reason that the delta function appears in the definition is related to the
fundamental inability to measure anything at a point. Rather, we always mea-
sure over an interval. The integral of the random noise over a time interval δt,
denoted η(t; δt)
η(t; δt) =
∫ t+δt
t
dt′ η(t′)
is a normally distributed stochastic vector with expectation value equal to zero
and variance equal to Nδt, where N is the number of dimensions of η(t). This
is seen as follows. Since η(t; δt) is defined as a sum of many random noise
terms, the central limit theorem gives that it will be normally distributed. The
expectation value is calculated as
〈η(t; δt) 〉 =
〈∫ t+δt
t
dt′ η(t′)
〉
=
∫ t+δt
t
dt′ 〈η(t′) 〉
= 0
This is not a surprising result (the expectation value is zero at each time point
and the sum of many zeros is still zero). Since the expectation value is zero, the
covariance matrix is calculated as
V(η(t; δt) ) = 〈η(t; δt)⊗ η(t; δt) 〉 − 02
=
〈∫ t+δt
t
dt′ η(t′) ⊗
∫ t+δt
t
dt′′ η(t′′)
〉
=
〈∫ t+δt
t
dt′
∫ t+δt
t
dt′′ η(t′)⊗ η(t′′)
〉
=
∫ t+δt
t
dt′
∫ t+δt
t
dt′′ 〈η(t′)⊗ η(t′′) 〉
=
∫ t+δt
t
dt′
∫ t+δt
t
dt′′ I δ(t′ − t′′)
=
∫ t+δt
t
dt′ I
= I δt
The total variance is found by adding the diagonal elements of V
σ2(η(t; δt) ) =
N∑
i=1
δt = Nδt
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Notice that the expectation value of η(t; δt) is still a vector while the variance
is a scalar. The more dimensions and the larger the time interval, the larger
the variance will be. That is, the more directions the noise has to fluctuate in,
and the longer the time interval in which it can do it, the more (measured as
variance) will the noise have been away from zero.
The random walk
The random walk performed by a particle with position vector r(t) is described
by the differential equation
dr
dt
= ρη(t) (3.21)
where η(t) is a random noise as defined above and ρ is a scalar.
Since η is a stochastic vector, r is also a stochastic vector. It does therefore
not make sense strictly mathematically to take the derivative of r. However
physically the picture is clear. The particle is constantly changing speed and
direction, going hither and dither without any preference in space and time.
To determine where the particle is expected to be at time t we first integrate
(3.21) between 0 and t,
r(t)− r(0) = ρ
∫ t
0
dt′ η(t′) = ρη(0; t) (3.22)
The properties of η(0; t) were derived above. The mean displacement of the
particle is given by
〈 r(t)− r(0) 〉 = ρ 〈η(0; t) 〉 = 0
while the mean squared displacement is given by
〈 (r(t)− r(0))2 〉 = ρ 〈η(0; t)2 〉 = ρNt
The mean displacement and mean squared displacement of the random walker
can be interpreted as follows. Imagine a large number of random walkers all
starting in the same point. At time t, each individual walker are in general
not at the starting point. But taking the mean of all walker positions at time
t gives the starting position, that is the spreading of walkers is symmetrical
around the starting position. How far are the walkers from the starting point at
time t? The mean squared displacement (which is equal to the variance) gives
the answer: at time t, approximately 32% of the walkers are further than
√
ρNt
away from the starting point.
Discrete random walk
Define
tj ≡ jδt
rj ≡ r(tj)
ηj ≡ η(tj , δt)/
√
δt
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where ηj as defined here is a stochastic vector with zero mean and unit variance
in each dimension. Using (3.22) we can now write
rj+1 = rj + ρ
√
δtηj (3.23)
This discretized version of the random walk2 is easily implemented on a com-
puter.
3.6.2 The persistent random walk
The persistent random walk is described by the following stochastic differential
equation (SDE)
dv
dt
= −β v(t) + σ η(t) (3.24)
where β and σ are scalars, v(t) is the velocity at time t of the persistent random
walker, and η(t) is a random noise as defined above. The persistence time of a
persistent random walk is defined as P ≡ 1/β.
Discrete persistent random walk
The difference between the current velocity v(t) and the velocity a time δt later,
v(t+ δt), is given by
v(t+ δt)− v(t) =
∫ t+δt
t
dt′
dv
dt
=
∫ t+δt
t
dt′
(− β v(t′) + σ η(t′))
= −β v(t) δt+ σ η(t; δt) (3.25)
where the calculation of the first term in (3.25) is based on the first order
approximation that v(t′) is essentially constant over the short time interval δt.
Just as above we define
tj ≡ jδt
xj ≡ x(tj)
vj ≡ v(tj)
ηj ≡ η(tj , δt)/
√
δt
From Eqn. 3.25 we can now write
vj+1 − vj = −β vj δt+ σ
√
δtηj
which can be rewritten as
vj+1 = (1− δt β)vj + σ
√
δtηj (3.26)
2which is equivalent to with the Wiener process, as used by statisticians (compare with
Eq. 2.1 in Higham (2001)).
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3.6.3 General models for cell motility
The Ornstein-Uhlenbeck process
The persistent random walk presented in Sec. 3.6.2 has been used to model cell
motility in numerous studies, the first time probably by Gail and Boone (1970).
When used in this context it is known as the Orstein-Uhlenbeck (OU) process
(Ornstein, 1919, Uhlenbeck and Ornstein, 1919), and usually written
P
dv
dt
= −v(t) +
√
2D η(t) (3.27)
(compare (3.27) with (3.24) where β = 1/P and σ =
√
2D/P ).
Reading data
As will be shown in the following, the OU process cannot be used to model
the motility of HaCaT and NHDF cells. This can be seen by plotting the
motility data in various ways that bring forth the basic characteristics of the
cells’ behavior. Additionally, such plots also point at the kinds of models that
do capture the observed behavior. For HaCaT cells, the plots are shown in
Fig. 3.13. The individual plots will be presented below, and their agreement or
disagreement with the OU model discussed.
Equation (3.27) states that a cell’s acceleration dv/dt at any time t is a random
vector with expectation value −v(t)/P , and with equal RMSD in all directions.
This statement can be compared with experimental data in a straightforward
and model-independent manner.
Figure 3.13A shows experimentally measured accelerations of HaCaT cells on
a substrate of collagen plotted against their instantaneous speed. If these data
can be described by (3.27), Fig. 3.13A1 accelerations parallel to the velocity
should average locally, as function of the speed v, to −v/P , with P a parameter
to be fitted. The red data in Fig. 3.13B show that they do. Also, Fig. 3.13A2
accelerations orthogonal to the velocity should average to 0 locally, for all values
of v. The green data in Fig. 3.13B show that they do.
Furthermore, the accelerations in Fig. 3.13A should scatter about these aver-
ages with the same v-independent RMSD,
√
2D/∆t/P , according to the OU
model (see also (3.26)). Here ∆t = 15min is the time lapse between successive
position measurements rj from which velocities and accelerations were calcu-
lated; see Sec. 1.4. The blue and magenta data in Fig. 3.13B show the RMSD of
each component of the accelerations. Within their error bars, the two RMSDs
are identical. But they depend on the speed v, essentially as a first-degree
polynomial, in disagreement with the OU model.
Finally, the accelerations in Fig. 3.13A should be normally distributed about
their averages and uncorrelated, according to the OU model. Fig. 3.13C shows
clearly that they are not normally distributed. Both are more similar to two
exponential distributions placed back-to-back. This is not just due to time-lapse
recording, i.e., a discretization effect due to ∆t = 15min. One can prove that
the OU process gives a purely normal distribution when studied with any finite
value for ∆t.
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Figure 3.13: Motility of HaCaT cells on collagen surface.
(A) Experimentally measured components of acceleration parallel (A1) and perpen-
dicular (A2) to the cell’s velocity, plotted against the cell’s speed.
(B) Red and green data points are the mean values of the acceleration’s two compo-
nents shown in panels A1 and A2, respectively, as functions of speed. Blue/magenta
data points show RMSD of same quantities, parallel/orthogonal component. Thick
curves show theoretical expectation values of same quantities, according to the Ha-
CaT model, fitted to data in panels B, E, and F1 simultaneously. Pairs of thin lines
next to thick curves show ±1 SD from thick curve, according to HaCaT model’s pre-
diction of experimental data points’ scatter.
(C) Distribution of acceleration about its mean value, in units of distribution’s RMSD,
averaged over speeds v larger than 0.5〈v〉. Panels C1/C2 show distribution of compo-
nent parallel/orthogonal to the velocity. Histograms show experimental results. Thick
curves (averages) surrounded by two thin curves (average ±1 SD) show predictions of
the HaCaT model, not a fit to data shown here.
(D) Correlation functions for acceleration’s scatter about its mean. Panels D1/D2 are
the autocorrelation function of parallel/orthogonal component, normalized to unity at
time difference zero. Panels D3/D4 are the cross-correlation function between parallel
and orthogonal component, for positive/negative time difference, in units of (RMSD
of parallel component)×(RMSD of orthogonal component). Curves are theoretical ex-
pectation values.
(E) Data points are experimental velocity autocorrelation function φ(t). Error bars
on data points underestimate true scatter as they were computed from experimental
data that are correlated due to persistence of cell motion. The thick line is a guide to
the eye connecting theoretical result for φ(t), computed from 15-min time-lapse posi-
tion measurements, exactly as in experiment. Two thin lines are ±1 SD on theoretical
result.
(F1) Histogram is distribution of observed speeds v, binned on v-axis, and plotted with
lin-log axis. Thick curve is HaCaT model’s distribution of speeds. (F2) Histogram
shows distribution of observed speeds v, binned on v2 axis, and plotted with lin-log
axis, so a Gaussian velocity distribution p(v) would fall on a straight line. Curves are
the same as in panel F1.
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That the noise is uncorrelated, just as in (3.19), is shown in Fig. 3.13D.
From (3.27), the velocity autocorrelation, φ(t), can be calculated as
φ(t) ≡ 〈v(t) · v(t)〉 = nD
P
e−|t|/P
Fig. 3.13E shows that the velocity autocorrelation function for HaCaT cells is
not a simple exponential function, as it is in the OU process. On the contrary,
the data are fitted perfectly by a sum of two exponentials.
Fig. 3.13F shows the experimental result for the velocity probability distribu-
tion, p(v), as a histogram of observed velocities, binned on the v-axis in panel
F1, and binned on the v2 axis in panel F2, both with logarithmic second axis.
Isotropy of the surface on which the cells crawled, makes p(v) depend only on
the speed v, and not on the direction of the velocity. Consequently, if p(v)
is a Gaussian distribution on the v-plane, as in the OU model, its graph is a
straight line in panel F2. This is clearly not the case, according to the histogram
of observed velocities.
Fig. 3.14 shows results for NHDF cells on TCPS. They move approximately
twice as fast, on average, and are also in other ways more dynamic than ker-
atinocytes. Their mean acceleration parallel to their velocity, e.g., decreases
somewhat faster than proportional to v (red data points in Fig. 3.14B). Also,
the RMSD of the acceleration differs for the two directions: its component or-
thogonal to the direction of motion is almost constant as in the OU model. But
its component parallel to the direction of motion increases with v and doubles
its value in the window shown.
Properties of an unknown model
Figure 3.13E shows that the velocity autocorrelation function for HaCaT cells
is fitted perfectly by a sum of two exponentials. We consequently assume that
φ(t) = φ1e−|t|/P1φ2e−|t|/P2 (3.28)
and ask which generalization of the OU model might yield this function and the
other properties of the data shown in Fig. 3.13. Such a generalization must, like
the OU model, describe the rate of change of the cell’s velocity. This acceleration
cannot depend on a cell’s position r; nor explicitly on spatial direction or time,
because the cells crawl on surfaces that are homogenous and isotropic, and their
environment is kept constant. So the acceleration must depend only on the cell’s
velocity, like in the OU model. We expect some memory in a cell, however, so the
acceleration may depend not only on the current velocity, as in the OU model,
but on past velocities as well. This dependence must be linear, like in the OU
model, to ensure that 〈dv/dt〉v ∝ v as in the red data in Fig. 3.13B. The noise
term seems to have an isotropic amplitude σ, as in the OU model, because blue
and magenta data in Fig. 3.13B coincide. But unlike the OU model’s amplitude,
this amplitude must be speed dependent, σ = σ(v), according to the same data.
The noise itself was uncorrelated to a good approximation, when measured with
our 15-min time resolution; see Fig. 3.13D. We consequently model the noise as
uncorrelated on all timescales, to keep the model as simple as our data allow.
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Figure 3.14: Same as Fig. 3.13, but for NHDF cells on surface of TCPS.
(A) and (B) Experimentally measured components of acceleration and their
mean (red and green) and RMSD (blue and magenta) values. For details about
these panels and the rest in this figure, refer to Fig. 3.13.
(C) Distribution of accelerations. (C1) The asymmetry of the distribution for
NHDF cells is more pronounced than for HaCaT cells. The NHDF model’s
prediction for this distribution and that in panel C2 is shown as red lines. It is
not a fit. The model was fitted only to data in panels B, E, and F1.
(D) Correlation functions. (D1) Red curve is the NHDF model’s prediction
for the autocorrelation function for the acceleration’s scatter about its mean in
direction parallel to the velocity. Like the experimental data, it is small, but
nonvanishing, though the model’s noise term is uncorrelated Gaussian.
(E) Velocity autocorrelation function. (F) Distribution of speeds.
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This list of properties of the yet unknown model, narrows it down to the integro-
differential equation
dv
dt
= −K ∗ v + σ(v)η(t) (3.29)
whereK is a memory kernel yet to be determined, except causality demands that
K(t) = 0 for t < 0: the future must not affect the present. The asterisk denotes
convolution, i.e., (K ∗ v)(t) = ∫ t−∞K(t− t′)v(t′)dt′. K is a scalar function of t,
as opposed to a tensor of rank two, because the surface on which the cells move,
is isotropic to them (see Sec. 1.4). When this equivalence principle is enforced
on the theory we wish to find, mathematics gives that K must transform under
spatial rotations as an invariant tensor, i.e., be a scalar. If the isotropy of space
is broken, as it is in chemotactic and galvanotactic experiments, K is a tensor
of rank two.
HaCaT model
Equations (3.28) and (3.29) have only one solution for K as shown in paper II.
Inserted in (3.29), it results in the equation of motion
dv
dt
= −βv(t) + α2
∫ t
−∞
dt′e−γ(t−t
′)v(t′) + σ
(
v(t)
)
η(t) (3.30)
Here α, β, and γ are known functions of P1, P2, and φ1/φ2, and satisfy βγ/α2,
as they must for velocities to remain finite under the dynamics of (3.30); see
Appendix A, paper II. The term in (3.30) containing β represents “loss of mem-
ory” of velocity at average rate β−1. The term containing α2, on the other
hand, represents “memory” with characteristic time γ−1 and strength α2/γ.
Inspired by the data in Fig. 3.13B, we choose
σ(v) = σ0 + σ1v (3.31)
Equations (3.30) and (3.31) defines our model for HaCaT cells.
A small trick simplifies numerical integration of (3.30) as well as some analytical
considerations. Rather than doing the convolution integral in (3.30) at each time
step of its integration, we introduce the auxiliary velocity
V (t) = α
∫ t
−∞
dt′e−γ(t−t
′)v(t)
and solve a mathematically equivalent problem of two coupled, but ordinary,
SDEs,
dv
dt
= −βv(t) + αV (t) + σ(v(t))η(t)
dV
dt
= αv(t)− γV (t)
the discretization of which follows along the same lines as in Secs. 3.6.1 and
3.6.2.
The red lines in Fig. 3.13 show the result of fitting the HaCaT model to data
(using an implementation of the Levenberg-Marquardt algorithm as discussed
in Sec. 3.5.1).
Chapter 3. Fitting models to data 75
NHDF model
The behavior of NHDF cells, as shown in Fig. 3.14 and briefly discussed above,
is captured by two modifications of (3.30): Firstly, we replace the constant β
with an increasing function β(v). A first-degree polynomial, β(v) = β0 + β1v,
turns out to do the job, whereas a second degree polynomial does not further
improve the agreement between theory and data. Secondly, we replace the scalar
function σ(v) with the tensor σ¯(v) = σ‖(v)vˆ ⊗ vˆ + σ⊥(v)vˇ ⊗ vˇ. Here vˆ = v/v,
vˇ is a unit vector orthogonal to v; and σ‖(v) and σ⊥(v) are the RMSDs of the
random components of the acceleration, parallel and orthogonal to the velocity,
respectively. The data in Fig. 3.14 suggest that σ‖(v) and σ⊥(v) are different
first-degree polynomials in v, but with σ‖(0) = σ⊥(0), so σ¯(v) contains a total
of three free parameters to be fitted, where σ(v) contained two. This defines
our motility model for NHDF cells.
The red lines in Fig. 3.14 show the result of fitting the NHDF model to data.
Same cells on different surfaces
Motility data were collected for NHDF cells on four different surfaces: glass,
TCPS, fibrillar collagen, and molecular collagen, and for HaCaT cells on fib-
rillar collagen and molecular collagen (HaCaT cells did not show measurable
motility on glass and TCPS during the first 24 h of the experiment). The re-
sults when fitting the models derived above to each of these datasets (see paper
II), show that the models are cell-type specific in the sense that they capture
the motility patterns on each surface; only the parameters vary. Consequently,
these parameter values can be used to characterize the surface as well as the
range of responses of the cell.
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Integrating biological knowledge
In this chapter, initiatives to structure and order the body of biological knowl-
edge in ways that are accessible to automated computer queries are presented.
In Sec. 4.1, the basic issues of describing gene and protein function and compar-
ing their sequences, are described. Building on this, Sec. 4.2 describes efforts
to formalize the descriptions of how genes, proteins, and metabolites relate to
one another through networks. Research examples of these issues are given
in Secs. 4.3–4.5, all from paper I. Finally, Sec. 4.6 discusses methods to au-
tomatically extract knowledge from literature databases — text mining. Such
automatic extractions can be used both for increasing the amount of structured
knowledge as discussed in the first sections of the chapter, and to retrieve in-
formation about the specific results of an experiment.
4.1 Annotation, sequence similarity, and controlled
vocabularies
When a gene or protein and its function is discovered through experiments, a
brief description of this function is included when the gene or protein sequence
is uploaded to a public database (such as GenBank1). With the advent of high-
throughput sequencing, many putative genes and unigenes have been identified
whose functions have not yet been investigated in detail. Such sequences are
compared to genes and proteins with known function, and if genes or proteins
with significant sequence similarity are found, their annotation are transferred
to the new genes. These functions can then be confirmed or disproved later by
directed experiments.
The most commonly used algorithm for comparing sequences in this manner
is the BLAST (Basic Local Alignment Search Tool) algorithm (Altschul et al.,
1990). BLAST finds statistically significant similarities between sequences by
evaluating alignments. Alignments are found using a variation of the dynamic
programming approaches implemented in the Needleman-Wunsch (global align-
ment) and Smith-Waterman (local alignment) algorithms. The optimal align-
ment is calculated using statistics specifically developed for this (Korf et al.,
1www.ncbi.nih.gov/Genbank/index.html
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2003), and reported as an E-value (the number of alignments expected by chance
between a query sequence and all sequences in the database).
A lot of putative genes and unigenes have no sequence similarity to known genes,
and their functions simply await discovery. In general however, the amount of
new and inferred annotation is ever increasing. To facilitate the comparison
of annotation between genes and organisms, and the communication between
researchers, a group of model organism database providers has proposed, and
is actively developing, a controlled vocabulary to use for gene annotation: the
Gene Ontology, GO (Ashburner et al., 2000). The vocabulary is divided in
three, to aid in the description of (1) the molecular functions of gene products,
(2) their placement in and as cellular components, and (3) their participation
in biological processes. Terms in each of the vocabularies are related to each
other in a polyhierarchical manner, using ‘is-a’ and ‘part-of’ relationships. More
formally, the terms and their relationships are structured as a directed acyclic
graph. This means that a given term can relate to any other term, as long as
this does not result in any term eventually being connected to itself. That is,
as long as a series of terms and their relations does not produce a cycle. In
practice, terms often relate to each in simple hierarchies where general terms
divide into several distinct and more specific terms. Each GO term consists of
a unique alphanumerical identifier, a common name, and a definition.
One can use such controlled vocabularies to test if any terms are overrepresented
among groups of genes, compared to all genes measured. The basic idea of the
testing is as follows: In an experiment, the expression of m genes are measured.
Of these, mc genes are tested as differentially regulated. Assume that out of the
m genes, n of them have been annotated with the term “Protein biosynthesis”.
Among the group of differentially regulated genes, nc of them are annotated
with this term. The larger the ratio nc/mc compared to the ratio n/m, the
less likely it is that this term appears among the differentially regulated genes
simply due to random picking. Two approaches to calculate this likeliness are:
Fisher’s Exact test, which uses the hypergeometric distribution to calculate the
probabilities of all outcomes when assuming random picking of terms, or the
Chi-Square (goodness-of-fit) test, which uses the chi-square statistic to evaluate
the difference between nc/mc and n/m (Upton and Cook, 2004).
4.2 Biochemical pathways and networks
To make the accumulating knowledge about the interactions between com-
pounds in metabolic-, genetic information processing-, signal transduction-, and
other pathways, easily accessible, databases/tools that store and order such in-
formation have been developed. Examples include the Kyoto Encyclopedia of
Genes and Genomes, KEGG (Kanehisa et al., 2006), the Gene Map Annota-
tor and Pathway Profiler, GenMAPP (Dahlquist et al., 2002), and MAPMAN
(Thimm et al., 2004). For pathways stored in the databases, the integration of
these with high throughput data is in general achieved by coloring each of the
compounds in the pathway using a legend that relates to the expressions mea-
sured. For example, by coloring upregulated genes red, downregulated genes
blue, non-changing genes grey, and genes not measured white. One does not
necessarily need to measure the specific compounds of a pathway in order to get
Chapter 4. Integrating biological knowledge 79
valuable information. For example, if the genes coding for the specific enzymes
of a metabolic pathway are identified, one can color the enzymes according to
the regulation of these to get a representation of the transcriptional control of
the metabolic pathway.
To store and represent the pathways in databases, more or less systematic lan-
guages are used to describe which compounds relate to each other and in what
manner. A generalization of this is the Systems Biology Markup Language,
SBML (Hucka et al., 2004). SBML is an XML-like computer-readable format
developed for representing models of biochemical reaction networks. The gen-
erality of such a language allows pathways and models to be easily developed
and shared by the community, and ancillary software modules to be quickly
developed and integrated in the overall framework when needed. For exam-
ple, having created a pathway one can simulate the dynamics of it by using
the SBML differential equation solver, and this can then be compared to e.g.
time-series measurements when they become available. The task of construct-
ing a language that captures and concisely describes the intra- and extracellular
networks of an organism at all levels (and between levels), is obviously not an
easy one. For example, the flexibility of the XML approach (on which SBML
is based) allows the same thing to be described in several ways which are not
obviously identical (Wang et al., 2005). These authors therefore suggest that
an approach that better captures the workings of the cell in an unique manner
might be the reference-document format (RDF). In general, the development
of language standards, ontologies, and databases that can store and analyze
pathway information is one of the key efforts that can accelerate the overall rate
of scientific discovery (Quackenbush, 2006) — and the optimal approach will
ideally be selected based on what works and produces results and new insights.
An example of the additional insights gained when systematically storing net-
works in databases is the following: As shown by Guimera` and Amaral (2005),
when exploring the overall topology of the entire network of interactions in a cell
(as extracted from KEGG), functional modules appear — around 15 of them.
That is, each network is divided into around 15 modules that only have a few
connections between them. Furthermore, one can define compounds in these
networks based on how they connect within and between modules and relate
this to how they are affected by evolutionary constraints and pressures.
4.3 Research example: Functional classification of
candidate genes and mapping to pathways
(paper I)
Using the EST-sequence reads from the crop EST database CR-EST (Ku¨nne
et al., 2000); genes on the 10k-array were annotated as follows. (1) By a
BLASTX search against the non-redundant (nr) protein database at GenBank2
to assign function by homology to similar genes, (2) by a TBLASTX search
specifically against the Arabidopsis genome (The Arabidopsis Information Re-
source3 to identify ortholog genes, and (3) by a BLASTN search against the
2ftp.ncbi.nlm.nih.gov/blast/db
3ftp.arabidopsis.org/home/tair/home/tair/Sequences/blast_datasets/
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TIGR barley Gene Index database4. The TIGR barley Gene Index constitutes
an assembly of all available barley ESTs into contigs, and TIGR annotates
these contigs using GO terms and EC numbers (enzyme identification numbers)
when possible. Hence, using the mapping obtained by blast between genes on
the 10k-array and TIGR contigs, GO terms were assigned to 4868 genes on
the array (47%), and EC numbers to 1446 genes on the array (14%). Besides
the functional classification of genes based on GO terms, the candidate genes
were also classified into 33 different functional groups resembling the major
functional classes in the MAPMAN system (Thimm et al., 2004). For those
candidate genes where GO terms were available, the two methods of functional
classification were generally in agreement.
4.4 Research example: Overrepresented GO terms
(paper I)
For each type of regulation of the candidate genes (each part of the Venn
diagram in Fig. 3.2B in Sec. 3.3.6), Fisher’s exact test was used to test for
over-representation of GO-defined biological processes, cellular components, or
molecular functions between these genes and the remaining genes on the array.
A GO term was judged as significantly overrepresented when the Bonferroni-
corrected p-value was below 0.05. For three types of regulation significantly over-
represented GO terms were found: (1) Genes specifically upregulated in infected
cells (7 GO terms), (2) genes upregulated in both infected and resistant cells (16
GO terms), and (3) genes downregulated in infected and resistant cells (5 GO
terms). Focusing on the overrepresentation of 13 genes encoding protein com-
ponents of the translation apparatus (GO term 0006412: protein biosynthesis)
that are specifically upregulated in infected cells: Holcik and Sonenberg (2005)
have linked sensing and response to stress to initiation of translation in terms
of ribosome recruitment to internal ribosome-entry sites and cap-independent
translation. Regulation of ribosome biogenesis is in yeast and mammalian cells
controlled by the enzyme TOR (target of rapamycin) (Inoki et al., 2005). Signal
cues from external or internal factors, including stress, modulate the activity of
TOR which co-ordinately control events of cell growth, protein synthesis and cell
death. We therefore speculate that increased translational activity in infected
cells reflects aspects of balance between nutrient requirement and survival of
the cell.
4.5 Research example: Biochemical pathways
(paper I)
Among the 332 candidate genes identified as described in Sec. 3.3.6, only 64
of them have been assigned with an EC number. Since the following analysis
is focused on identifying overall trends in the regulation of pathways, a larger
number of false positives than the number we expect when FDR < 0.05 is
4www.tigr.org/tigr-scripts/tgi/T_index.cgi?species=barley
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acceptable. Therefore, for this analysis only, we set the significance threshold to
FDR < 0.15, thus including 774 genes with 136 having an EC number. With this
cutoff, metabolic pathways involving energy production and sugar conversions
and phenylpropanoid biosynthesis appear to be regulated differently between
infected, resistant and control cells. Below, the findings and hypotheses relating
to mapping expression values to the starch and sucrose metabolic pathway (see
Fig. 4.1) are discussed.
The enzyme UDP-glucose 6-dehydrogenase (EC 1.1.1.22; HH01A03) is upreg-
ulated in resistant cells. Presumably, this enzyme converts UDP-glucose to
UDP-D-glucuronate for pectin biosynthesis. The coincident downregulation of
poly-galacturonase (EC 3.2.1.15; HX04D02), involved in pectin degradation,
suggests changes that could lead to cell wall fortification by pectin enrichment
(Vogel et al., 2004). In line with this argument, Arabidopsis knock-outs of a
pectate lyase gene (EC 4.2.2.2) have increased cell wall pectate content and
show enhanced powdery mildew resistance (Vogel et al., 2002). Furthermore,
a pectin esterase gene (HY10N07) is upregulated in resistant cells. This pre-
sumably also contributes to the cell wall strengthening by pectin demethylation
(Vogel et al., 2004). The importance of pectin is further suggested by the fact
that powdery mildew conidia contain pectinase presumably because this con-
veys an evolutionary advantage in pathogenesis, perhaps in facilitating cell wall
penetration (Suzuki et al., 1998).
Central to powdery mildew nutrition is sucrose synthase (EC 2.4.1.13; HU03P12,
HY10G10, and five others). We find that sucrose synthase is upregulated ex-
clusively in infected cells (and sometimes even downregulated in resistant cells).
Collinge et al. (1994) previously noted sucrose synthase upregulation following
powdery mildew inoculation, but they used bulk leaf samples that also con-
tained papilla-resistant cells; in these we found no such effect. Sucrose synthase
catalyzes the reversible conversion of sucrose and UDP into fructose and UDP-
glucose, and glucose is taken up preferentially by haustoria (Aked and Hall,
1993). This strongly suggests that sucrose synthase-mediated glucose genera-
tion would favor sugar uptake by the haustorium, which would, in turn, lead to
carbon import from the underlying tissues to supply to the infected cell.
4.6 Text mining
The usual method for reporting new discoveries is through the publication of
articles in reviewed journals. Most databases described here are initially based
on what has been reported in articles — although as the databases become more
and more known, results are also submitted directly. Considering that new re-
sults are produced at an ever increasing pace, and that the entire body of articles
is already immense (PubMed, a life-science article search and retrieval system,
covers around 12 million citations dating back to the mid-1960’s5), the task of
locating all relevant articles with respect to a given pathway or result is daunt-
ing. However, most of the articles are stored as text-files at the publishers web
site, and consequently, with the right tools the whole body of literature could in
principle be mined automatically for gene annotations, pathways, and relations
5http://www.ncbi.nlm.nih.gov/entrez/query/static/overview.html
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Figure 4.1: The starch and sucrose pathway as represented in KEGG. Enzymes
represented in boxes with blue border are measured on the 10k-array, and those
with black border are not. Boxes with white background have either not been
found in barley (black border) or are not differentially regulated (blue border).
For the differentially regulated genes, the following color codes are used for the
background: dark green: upregulated in resistant cells, red: upregulated in in-
fected cells, purple: upregulated in infected cells and either up- or downregulated
in resistant cells.
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between these and specific diseases, etc. A central issue in the development of
such tools is the ability to recognize gene and protein names in article text.
Researchers separated in time, research field, or organism studied have often
devised different names for compounds that (later are shown to) have similar
function. Renaming of such compounds is a slow process due to e.g. tradition.
Therefore, there is a plethora of different names for the same gene or protein.
In order to catalogue such names in a systematic manner, traditional classifiers
such as Support Vector Machines and Hidden Markov Models have been used
alone, or combined in an ensemble (Zhou et al., 2005). A simple use of such a
classification is to search the entire body of literature for any mentioning of a
group of genes of interest in relation to one or several keywords (Rubinstein and
Simon, 2005). For example, which of the genes significantly regulated in barley
epidermal cells infected with powdery mildew have previously been related to
“barley”, “powdery mildew”, “infection”, or a “stress” response in general? The
long -term goal, however, is to develop tools that automatically extract also the
relations between compounds (Zhou et al., 2005).
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Conclusions and perspectives
Each of the methods to study single-cell gene expression, cell motility, antibody
reactivity, and respiratory metabolism presented in this thesis has enabled the
investigation of hitherto uncharted areas. The model systems they have been
applied to generated interesting and novel data in their own right, and this guide
further research in these areas. But they also function as proofs-of-concept, and
application of the methods to other model systems are actively investigated. In
addition, ways to integrate the methods presented here (and other methods),
to improve the overall measurement coverage when studying systems of interest
are also pursued.
For the single-cell transcript profiling of barley attacked by powdery mildew,
follow-up experiments for several of the results have been designed. For ex-
ample, having identified a group of protein synthesis genes that are specifically
upregulated in infected cells, the immediate questions are: What controls this
upregulation? Do several mechanisms that just converge at this point in the
network, or is it just one factor, closely linked to the actions of the fungus.
Our hypothesis concerning the actions of the gene encoding TOR and its in-
volvement with these genes can only function as a guide for which independent
experiments to perform next, or independent datasets to integrate this knowl-
edge with. One approach to this would be to identify common motifs in the
promoter region of the protein synthesis genes, to detect transcription factors
that control the regulation. However, before embarking on this, it would be
helpful to know whether these genes display a coordinated response not just at
the 18 hai timepoint.
Because of this, and several other questions that were asked based on the find-
ings in the dataset, we designed and conducted a time-course study in which
we measured the gene expression in control and infected cells at 12, 15, 18, 21,
24, 36, and 48 hai. With these data, we did in fact find clear evidence that the
protein synthesis genes display a complex, coordinated response, see Fig. 4.2.
Since the barley genome has not been sequenced, the next difficulty is to de-
termine the promoter regions for these genes. One experimental technique is to
use a known sequence on the genome, e.g. an EST sequence, to design primers
and then sequence the upstream region. Such a “genome walking” protocol was
for example used by Mastyugin et al. (2004). However, it is very time consum-
ing. Therefore, an initial, bioinformatic approach would be to take advantage
of the fact that the rice genome, which is expected to be similar to the barley
genome in many respects (Jaiswal et al., 2006), has been sequenced. One could
therefore try to identify rice genes that are orthologues to the barley protein
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Figure 4.2: Expression profiles of protein synthesis genes.
synthesis genes, and then compare their promoter regions to detect common
motifs. Doing this, and using a Gibbs-sampling approach (Aerts et al., 2005)
for shared motif detection, the motif GCGGCGGCG was found in the rice promoter
regions of 11 out of 13 of the protein synthesis genes. The next step, which has
not yet been done, is to test whether this sequence motif is actually recognized
by proteins (transcription factors) in infected cells. This could be done using
an electrophoretic mobility shift assay. Also, this promoter is well described
in mammalian systems (Egr-1 in humans and Igf-1 in rats). One could com-
pare the cDNA sequences for the genes coding for these transcription factors
to an assembly of barley unigenes, to see if any sequences with high similar-
ity are present. If so, and if these barley unigenes also display the profile in
Fig. 4.2 (even though that would be lucky since genes coding for transcrip-
tion factors usually have very low expression), we might have found the control
point. Another, and very simple experiment, regarding the observation that cell
wall constituents seem to be upregulated in infected cells is to measure (using,
e.g fourier-transform infrared absorption spectroscopy) the amount of pectin in
infected cells and control cells and compare. Since pectin is a key structural
component in cell walls this would confirm the transcriptome measurements at
the metabolome level.
It would be interesting to apply the the single-cell transcript profiling method
to cells walking on different surfaces. Besides having quantitative measures of
the cells motility patterns, as calculated using the models developed in paper II,
one would then also get measures of the basic regulatory state inside the cells.
Preliminary gene expression studies for the response of motile cells to different
surfaces have been performed by Klapperich and Bertozzi (2004). They show
that genes involved in cell signaling, extracellular matrix remodeling, inflamma-
tion, angiogenesis, and hypoxia were all activated in cells on a collagen mesh
compared to TCPS. In the case of developing methods for growing artificial skin,
one could combine these methods, gathering knowledge on the optimal motility
behavior of the cells needed for skin growth, and then use high-throughput gene
expression measurements to help guide the engineering of cells that have these
properties. There are of course ethical issues regarding such engineering.
The motility models developed was also a proof-of-principle. The basic point
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of the paper was the development of a method for deriving motility models.
Therefore, the next step is to apply the method to other cells to show the general
applicability. This work has already begun for Dictyostelium discoideum (a soil-
living amoeba) and fish scale keratocytes.
For the antibody microarray, research in several directions are well underway.
Several datasets have been created and are currently analyzed, for example (1)
non-obese diabetic mice have been immunized with HSP60, as protein in oil
and as vector, to investigate disease mechanisms related to type 1 diabetes.
And (2) antigen repertoires from patients with different subtypes of multiple
sclerosis have been measured, and classifiers are being developed that can sepa-
rate these subtypes. Furthermore, serum samples for a large study designed to
investigate whether transplantation rejection responses can be detected before
the transplantation procedure, are currently being collected. This again strikes
at the theme concerning to what extent precise measurements of the state of a
system before the perturbation (being in this case the immune system and the
replacement of an organ) can be used to predict the response to the perturba-
tion. Several transcript profiling studies on the response to transplantation as
measured in peripheral blood have been performed (Jurcevic and Sacks, 2003)
and such an approach could obviously be combined with antibody detection.
Finally, concerning the method to measure free NADH in vivo. There are two
advantages to the use of a pulsed excitation regime: (1) Bleaching is reduced,
and (2) it allows collection of time-gated data in addition to the steady-state
spectra. Expanding the method initially introduced by Paul and Schnecken-
burger (1996), we made a series of measurements of NADH fluorescence lifetimes
in different metabolic states. The measurements of fluorescence decays have an
advantage over the steady-state measurements because the fluorescence lifetime
of bound NADH is an order of magnitude longer than that of a free NADH.
Consistent with this, our preliminary results indicated that the observed fluores-
cence of potato mitochondria has a longer lifetime in those states that have an
increased proportion of bound NADH. Quantification of this qualitative result,
however, requires a rigorous mathematical treatment and optimization of the
experimental setup, and is under development.
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